X-linked Nonsyndromic Hearing Loss

Genetic MONDO:0019586 Pathograph 16 Show in embeddings browser Nonsyndromic Hearing Loss X-linked Deafness

X-linked nonsyndromic hearing loss, also called DFNX, is a genetically heterogeneous form of hereditary hearing loss. Six loci (DFNX1-DFNX6) have been described, but the gene at DFNX3 remains unidentified. POU3F4 and SMPX have definitive ClinGen validity for nonsyndromic genetic hearing loss. PRPS1 is definitive only for the lumped PRPS1-deficiency continuum (DFNX1, CMTX5, and Arts syndrome), and AIFM1 is definitive for the broader auditory and sensory neuropathy spectrum rather than isolated nonsyndromic hearing loss. ClinGen classified the COL4A6-hearing loss, X-linked 6 relationship as Limited in February 2022. Human family and minigene observations provide variant-level evidence. A Col4a6-knockout mouse had normal click-ABR thresholds and cochlear morphology, narrowly arguing against simple loss of expression as a sufficient mechanism in that model without refuting variant-specific human causality. The human gene-disease relationship therefore remains unresolved rather than upgraded or broadly refuted. POU3F4 is the most common DFNX gene and is strongly associated with incomplete partition type III inner-ear malformation.

Ask OpenScientist

Ask a research question about X-linked Nonsyndromic Hearing Loss. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
5
Pathophys.
5
Phenotypes
1
Gaps
16
Pathograph
5
Genes
3
Medical Actions
6
Subtypes
7
Differentials
2
References
1
Deep Research
👪

Inheritance

1
X-linked inheritance HP:0001417
DFNX comprises hearing-loss loci and genes on the X chromosome. Female expression is gene specific: PRPS1 heterozygotes range from unaffected to unilateral or bilateral hearing loss and occasional subclinical neuropathy, influenced in part by X-inactivation. POU3F4 heterozygotes are usually unaffected, although hearing loss has been reported and systematic female imaging data are lacking. SMPX-associated hearing loss is often later, milder, and less penetrant in females than in males. Female carriers in the reported AIFM1 auditory-neuropathy families did not report auditory or sensory neuropathy. The few COL4A6 families do not establish reliable female penetrance or expressivity.
X-linked inheritance Expressivity: VARIABLE
Show evidence (6 references)
PMID:30065609 SUPPORT Other
"To date, six loci (DFNX1-6) and five genes (PRPS1 for DFNX1, POU3F4 for DFNX2, SMPX for DFNX4, AIFM1 for DFNX5 and COL4A6 for DFNX6) have been identified for X-linked non-syndromic hearing loss."
The review directly classifies the DFNX loci and genes as X-linked.
PMID:25182139 SUPPORT Human Clinical
"Female carriers may also be affected by unilateral or bilateral hearing impairment."
Human family data support variable auditory expression in PRPS1 heterozygotes.
PMID:30065609 SUPPORT Other
"Female carriers of a mutation in the DFNX2 usually show no hearing loss"
Review evidence supports usually absent but incompletely penetrant female expression for POU3F4.
+ 3 more references
◆

Subtypes

6
DFNX1 / PRPS1-related X-linked nonsyndromic hearing loss MONDO:0010577
PRPS1 hgnc:9462 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in PRPS1 (hgnc:9462). hgnc:9462 is a gene from the HUGO Gene Nomenclature Committee.
PRPS1-related DFNX1 is the hearing-loss-predominant end of the broader PRPS1-deficiency continuum rather than a cleanly separable gene-disease entity. Reported families include postlingual, bilateral, progressive hearing loss, sometimes with mild or subclinical peripheral neuropathy.
Show evidence (1 reference)
PMID:25182139 SUPPORT Human Clinical
"Whole-exome sequencing of a single Italian proband affected by non-syndromic HL identified a novel missense variant within the PRPS1 gene (NM_002764.3:c.337G>T (p.A113S)) segregating with post-lingual, bilateral, progressive deafness in the proband's family."
This family study directly links a PRPS1 variant to progressive nonsyndromic hearing loss.
DFNX2 / DFN3 / POU3F4-related X-linked hearing loss MONDO:0010576
POU3F4 hgnc:9217 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in POU3F4 (hgnc:9217). hgnc:9217 is a gene from the HUGO Gene Nomenclature Committee.
POU3F4-related DFNX2/DFN3 is the most frequent X-linked nonsyndromic hearing-loss subtype and is characterized by severe congenital or childhood hearing loss with incomplete partition type III inner-ear malformation in many affected individuals.
Show evidence (2 references)
PMID:37371790 SUPPORT Other
"POU3F4 is the gene most commonly associated with X-linked deafness (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked non-syndromic hearing loss."
This review establishes POU3F4 as the main DFNX gene and links it to the DFNX2/DFN3 subtype.
PMID:37371790 SUPPORT Other
"The clinical features of POU3F4-related hearing loss include a pathognomonic malformation of the inner ear defined as incomplete partition of the cochlea type 3 (IP-III)."
The review directly supports IP-III as the characteristic POU3F4-related malformation.
DFNX3 / unresolved X-linked nonsyndromic hearing-loss locus
DFNX3 is a mapped X-linked nonsyndromic hearing-loss locus for which no causal gene has yet been identified; it accounts for the gap between six named DFNX loci and five established genes.
Show evidence (1 reference)
PMID:30065609 SUPPORT Other
"To date, six loci (DFNX1-6) and five genes (PRPS1 for DFNX1, POU3F4 for DFNX2, SMPX for DFNX4, AIFM1 for DFNX5 and COL4A6 for DFNX6) have been identified for X-linked non-syndromic hearing loss."
The six-locus/five-gene enumeration documents that DFNX3 remains a locus without an identified causal gene.
DFNX4 / SMPX-related X-linked nonsyndromic hearing loss MONDO:0010238
SMPX hgnc:11122 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in SMPX (hgnc:11122). hgnc:11122 is a gene from the HUGO Gene Nomenclature Committee.
SMPX-related DFNX4 is usually progressive nonsyndromic hearing loss. Truncating SMPX variants are associated with DFNX4 auditory phenotypes, while nontruncating variants can be associated with non-auditory myopathy phenotypes.
Show evidence (1 reference)
PMID:21549342 SUPPORT Human Clinical
"In a Dutch family with an X-linked postlingual progressive hearing impairment, a critical linkage interval was determined to span a region of 12.9 Mb flanked by the markers DXS7108 and DXS7110. This interval overlaps with the previously described DFNX4 locus and contains 75 annotated genes...."
The original DFNX4 study directly establishes the X-linked postlingual progressive phenotype.
DFNX5 / AIFM1-related X-linked hearing loss MONDO:0010378
AIFM1 hgnc:8768 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in AIFM1 (hgnc:8768). hgnc:8768 is a gene from the HUGO Gene Nomenclature Committee.
AIFM1-related DFNX5 falls within an X-linked auditory and sensory neuropathy spectrum. Auditory neuropathy may precede numbness, unsteadiness, areflexia, and abnormal sensory nerve studies by months or years, so an apparently isolated auditory presentation requires longitudinal neurologic follow-up.
Show evidence (1 reference)
PMID:25986071 SUPPORT Human Clinical
"Variants in AIFM1 gene are a common cause of familial and sporadic ANSD and provide insight into the expanded spectrum of AIFM1-associated diseases."
This Chinese familial-and-sporadic cohort identified AIFM1 variants in an auditory-neuropathy phenotype; it does not establish that AIFM1 is a common cause of ANSD in every population.
DFNX6 / COL4A6-related X-linked hearing loss MONDO:0010484
COL4A6 hgnc:2208 HUGO Gene Nomenclature Committee (hgnc) Relation: this subtype is caused by variation in this gene This subtype is caused by variation in COL4A6 (hgnc:2208). hgnc:2208 is a gene from the HUGO Gene Nomenclature Committee.
DFNX6 is the reported COL4A6-associated X-linked hearing-loss phenotype. ClinGen classified the relationship as Limited in February 2022. A family and in-vitro minigene result support one splice variant, while another reported missense variant remained a variant of uncertain significance. Negative mouse-knockout hearing and cochlear-morphology results conflict with simple loss of expression being sufficient in that model; they do not test the reported human variants or broadly refute COL4A6 causality.
Show evidence (2 references)
PMID:33840813 SUPPORT In Vitro
"An in vitro minigene splicing assay revealed that c.951 + 1 G > T leads to skipping of exon 15, strongly suggesting a pathogenic role for this variant in the HL phenotype."
The minigene assay is variant-specific in-vitro evidence; it supports splice disruption but does not by itself establish the gene-disease relationship.
PMID:33840813 SUPPORT Human Clinical
"The p.Gly1091Ala variant is classified as a variant of unknown significance based on the variant interpretation guidelines."
The study explicitly preserves uncertainty for the reported missense variant.
?

Discussions and Knowledge Gaps

1
Why does complete Col4a6 loss in mice leave click-ABR thresholds and cochlear morphology normal when human COL4A6 variants have been reported with DFNX6, and do allele-specific effects rather than simple loss of expression explain the difference?
HUMAN MODEL MISMATCH OPEN mismatch_col4a6_knockout_human_hearing
Attached to
pathophysiology#Candidate COL4A6-associated cochlear basement-membrane involvement phenotypes#Sensorineural hearing impairment
The knockout is a narrow refutation of simple loss of Col4a6 expression being sufficient to produce severe hearing loss or cochlear malformation in this mouse model. It does not test the reported human missense or splice alleles and therefore does not broadly refute human COL4A6 causality. The mismatch matters because a null model could miss dominant-negative, aberrant-heterotrimer, allele-specific splicing, species-specific basement-membrane, or frequency-specific auditory effects.
Proposed experiments
Allele-matched Col4a6 knock-in and knockout comparison
exp_col4a6_allele_matched_mouse_comparison
Compare mice carrying orthologous versions of the reported human p.Gly591Ser missense and c.951+1G>T splice variants with the existing null allele and wild-type controls. Measure frequency-specific ABR and DPOAE thresholds, cochlear microanatomy, collagen alpha5-alpha6-alpha5(IV) assembly, and basement-membrane ultrastructure across development.
Decision criterion
An auditory or cochlear phenotype confined to a reported-variant knock-in, with abnormal collagen heterotrimer assembly, would support an allele-specific mechanism missed by the null model. Normal auditory, structural, and collagen-assembly readouts in both knock-in models would weaken the reported variants' proposed cochlear mechanism.
Isogenic human inner-ear model of COL4A6 variant and null alleles
exp_col4a6_isogenic_human_inner_ear_models
Engineer the two reported COL4A6 variants and a matched null allele in human iPSC-derived inner-ear or cochlear basement-membrane models, then compare transcript splicing, alpha6(IV) protein incorporation, heterotrimer assembly, extracellular-matrix organization, and rescue after correction of each allele.
Decision criterion
Variant-specific abnormalities that are rescued by correction but are absent from the null line would bridge the mouse-human mismatch and support a non-null mechanism. Absence of reproducible variant-specific abnormalities after isogenic correction and rescue would weaken the proposed human cochlear mechanism.
Show evidence (1 reference)
PMID:33848312 REFUTE Model Organism
"Hence, loss of Col4a6 gene expression in mice showed normal click ABR thresholds and normal cochlear formation, which differs from humans with the COL4A6 missense mutation c.1771G>A, p.Gly591Ser."
This abstract-level negative result narrowly refutes simple loss of expression as sufficient in the mouse model. It does not test the human alleles or refute broad human gene-disease causality.
⚙

Pathophysiology

5
PRPS1 enzymatic activity deficiency
DFNX1 missense variants reduce phosphoribosyl pyrophosphate synthetase 1 activity. The available human biochemical evidence establishes reduced enzyme activity but does not yet resolve why partial PRPS1 deficiency is selectively expressed as hearing loss in milder cases.
PRPS1 hgnc:9462 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves PRPS1 (hgnc:9462). hgnc:9462 is a gene from the HUGO Gene Nomenclature Committee.
Downstream
Progressive sensorineural hearing impairment Partial PRPS1 deficiency is associated with postlingual bilateral progressive hearing loss in DFNX1 families.
Show evidence (1 reference)
PMID:25182139 SUPPORT In Vitro
"All three variants result in a marked reduction (>60%) of the PRS-I activity in the patients' erythrocytes, with c.343A>G (p.M115V) and c.925G>T (p.V309F) affecting more severely the enzyme function."
Biochemical assays on patient erythrocytes support reduced PRS-I activity as the molecular consequence of the DFNX1 variants.
Candidate COL4A6-associated cochlear basement-membrane involvement
COL4A6 encodes the alpha-6 chain of type IV collagen in basement membranes. The ClinGen assertion classifies the DFNX6 relationship as Limited. Human segregation and a variant-specific minigene assay provide candidate support, while expression in animal inner ears supports biological plausibility. In conflict, Col4a6-knockout mice had normal click-ABR thresholds and cochlear morphology. That result narrowly argues against simple loss of expression being sufficient in the mouse model, but does not test allele-specific human effects or establish a general cochlear mechanism.
COL4A6 hgnc:2208 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves COL4A6 (hgnc:2208). hgnc:2208 is a gene from the HUGO Gene Nomenclature Committee.
Downstream
Sensorineural hearing impairment Reported human families support a possible COL4A6-hearing-impairment association, but the Limited ClinGen classification leaves gene-level causality and the intervening mechanism unresolved.
Show evidence (2 references)
PMID:23714752 SUPPORT Human Clinical
"Next-generation sequencing and subsequent segregation analysis detected a missense mutation (c.1771G>A, p.Gly591Ser) in the type IV collagen gene COL4A6 in all affected family members."
Human segregation in the original family supports, but does not by itself establish, the COL4A6 association.
PMID:23714752 SUPPORT Model Organism
"In situ hybridization and immunostaining demonstrated expression of the COL4A6 homologs in the otic vesicle of the zebrafish and in the murine inner ear, supporting its role in normal ear development and function."
Cross-species expression supplies model-organism support for an inner-ear role without overstating the unresolved mechanism.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for X-linked Nonsyndromic Hearing Loss Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

5
Ear 1
Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:27886419 SUPPORT Human Clinical
"A strong candidate variant (p.A82P) of PRPS1 is co-segregated with SNHL in X-linked recessive inheritance from one Korean multiplex SNHL family."
The family study directly supports sensorineural hearing loss in DFNX1.
Other 4
Progressive sensorineural hearing impairment HP:0000408 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Progressive sensorineural hearing impairment (HP:0000408). HP:0000408 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:25182139 SUPPORT Human Clinical
"Whole-exome sequencing of a single Italian proband affected by non-syndromic HL identified a novel missense variant within the PRPS1 gene (NM_002764.3:c.337G>T (p.A113S)) segregating with post-lingual, bilateral, progressive deafness in the proband's family."
The family study directly supports progressive hearing loss in DFNX1.
PMID:21549342 SUPPORT Human Clinical
"In a Dutch family with an X-linked postlingual progressive hearing impairment, a critical linkage interval was determined to span a region of 12.9 Mb flanked by the markers DXS7108 and DXS7110."
The original DFNX4 study directly supports postlingual progressive hearing loss.
Auditory neuropathy spectrum disorder
Show evidence (1 reference)
PMID:25986071 SUPPORT Human Clinical
"Variants in AIFM1 gene are a common cause of familial and sporadic ANSD and provide insight into the expanded spectrum of AIFM1-associated diseases."
This supports ANSD within the reported AIFM1-associated DFNX5 cohort; it does not establish AIFM1 as a common cause across unselected ANSD.
Incomplete partition type III Incomplete partition of the cochlea HP:0011373 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Incomplete partition type III, annotated with Incomplete partition of the cochlea (HP:0011373). HP:0011373 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:37371790 SUPPORT Other
"The clinical features of POU3F4-related hearing loss include a pathognomonic malformation of the inner ear defined as incomplete partition of the cochlea type 3 (IP-III)."
The review directly supports IP-III as the characteristic POU3F4-related malformation.
PMID:38498189 SUPPORT Other
"Mutations in the POU3F4 gene emerge as the principal pathogenic contributors to IP-III anomalies"
The IP-III review independently supports POU3F4 as the principal genetic contributor to this malformation.
Perilymphatic gusher during stapedectomy
Show evidence (1 reference)
PMID:37371790 SUPPORT Other
"Often, a perilymphatic gusher is observed upon stapedectomy during surgery, possibly as a consequence of an incomplete separation of the cochlea from the internal auditory canal."
The POU3F4 review directly supports perilymphatic gusher as a DFNX2-relevant surgical phenotype.
🧬

Genetic Associations

5
PRPS1 pathogenic variants (Definitive ClinGen validity for the lumped PRPS1 deficiency disorder, not for isolated DFNX1 alone)
Gene: PRPS1 hgnc:9462 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is PRPS1 (hgnc:9462). hgnc:9462 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (2 references)
CGGV:assertion_9416f6e2-8de3-48b0-9a1c-9bd11a59315c-2020-02-14T170000.000Z SUPPORT Other
"PRPS1 | HGNC:9462 | PRPS1 deficiency disorder | MONDO:0100061 | XL | Definitive"
ClinGen's definitive assertion explicitly concerns the lumped PRPS1 deficiency disorder that includes nonsyndromic and syndromic phenotypes.
PMID:25182139 SUPPORT Human Clinical
"Defects in this gene, encoding the phosphoribosyl pyrophosphate synthetase 1 (PRS-I) enzyme, determine either X-linked syndromic conditions associated with hearing impairment (eg, Arts syndrome and Charcot-Marie-Tooth neuropathy type X-5) or non-syndromic HL (DFNX1)."
The study directly identifies PRPS1 defects as the cause of DFNX1.
POU3F4 pathogenic variants (Definitive ClinGen gene-disease validity for nonsyndromic genetic hearing loss)
Gene: POU3F4 hgnc:9217 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is POU3F4 (hgnc:9217). hgnc:9217 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (2 references)
CGGV:assertion_4ab4f4a3-757d-4de3-90e7-42a229c360a0-2018-01-05T170000.000Z SUPPORT Other
"POU3F4 | HGNC:9217 | nonsyndromic genetic hearing loss | MONDO:0019497 | XL | Definitive"
ClinGen directly classifies the POU3F4-nonsyndromic hearing-loss relationship as definitive.
PMID:37371790 SUPPORT Other
"POU3F4 is the gene most commonly associated with X-linked deafness (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked non-syndromic hearing loss."
Review-level evidence supports POU3F4 as the most common DFNX gene.
SMPX pathogenic variants (Definitive ClinGen gene-disease validity for nonsyndromic genetic hearing loss)
Gene: SMPX hgnc:11122 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is SMPX (hgnc:11122). hgnc:11122 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (2 references)
CGGV:assertion_29773bee-1f13-43f6-bda0-c5a646efccd7-2017-09-12T160000.000Z SUPPORT Other
"SMPX | HGNC:11122 | nonsyndromic genetic hearing loss | MONDO:0019497 | XL | Definitive"
ClinGen directly classifies the SMPX-nonsyndromic hearing-loss relationship as definitive.
PMID:21549342 SUPPORT Human Clinical
"Subsequent next-generation sequencing (NGS) detected one variant within the linkage interval, a nonsense mutation in SMPX."
The original DFNX4 linkage study identifies a truncating SMPX variant.
AIFM1 pathogenic variants (Definitive ClinGen validity for the broader X-linked auditory and sensory neuropathy spectrum, not isolated nonsyndromic hearing loss)
Gene: AIFM1 hgnc:8768 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is AIFM1 (hgnc:8768). hgnc:8768 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE
Show evidence (2 references)
CGGV:assertion_a7afc3bb-7fce-45fd-a275-87277e22b1eb-2025-08-26T160000.000Z SUPPORT Other
"AIFM1 | HGNC:8768 | X-linked hereditary sensory and autonomic neuropathy with hearing loss | MONDO:0010378 | XL | Definitive"
ClinGen's definitive assertion is for the lumped auditory and sensory neuropathy spectrum rather than isolated nonsyndromic hearing loss.
PMID:25986071 SUPPORT Human Clinical
"We identified two missense mutations in AIFM1 in these families: c.1352G>A (p.R451Q) in the AUNX1 family and c.1030C>T (p.L344F) in the second ANSD family."
Family-based sequencing directly identifies AIFM1 variants in DFNX5-like auditory neuropathy pedigrees.
Reported COL4A6 variants (Limited ClinGen gene-disease validity; family and minigene observations provide variant-level partial evidence without establishing gene-level causality)
Gene: COL4A6 hgnc:2208 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is COL4A6 (hgnc:2208). hgnc:2208 is a gene from the HUGO Gene Nomenclature Committee.
Show evidence (2 references)
CGGV:assertion_d026ef00-c6f3-4aa8-a61a-b354b68fe043-2022-02-16T170000.000Z SUPPORT Other
"COL4A6 | HGNC:2208 | hearing loss, X-linked 6 | MONDO:0010484 | XL | Limited"
ClinGen retained Limited validity for COL4A6-related DFNX6 in February 2022; this is the governing expert-panel classification.
PMID:33840813 SUPPORT In Vitro
"An in vitro minigene splicing assay revealed that c.951 + 1 G > T leads to skipping of exon 15, strongly suggesting a pathogenic role for this variant in the HL phenotype."
The minigene assay supports splice disruption for one variant but does not independently establish categorical gene-level causation; the other reported missense variant remained uncertain.
💊

Medical Actions

3
Hearing-aid amplification
Platform: Device
Hearing aids are a primary treatment option for childhood-onset bilateral sensorineural hearing loss. The available abstract-level evidence supports this general treatment statement.
Target Phenotypes: Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:36633841 SUPPORT Human Clinical
"Primary treatments are hearing aids and cochlear implants."
The PubMed abstract supports hearing aids as a general primary treatment for childhood-onset bilateral sensorineural hearing loss; it does not support subtype-specific or genotype-directed claims.
Cochlear implantation for POU3F4/IP-III anatomy
Action: cochlear implantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cochlear implantation, annotated with Surgical Procedure (NCIT:C15329). NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Platform: Surgery
Cochlear implantation is a major intervention for severe POU3F4-related IP-III hearing loss, but the malformation increases surgical complexity and requires careful preoperative assessment and postoperative verification.
Target Phenotypes: Sensorineural hearing impairment HP:0000407 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Sensorineural hearing impairment (HP:0000407). HP:0000407 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:38498189 SUPPORT Other
"cochlear implantation currently serving as the predominant therapeutic approach."
The IP-III review supports cochlear implantation as the predominant therapeutic approach for this malformation-associated form of X-linked deafness.
Genetic Counseling
Action: Genetic CounselingNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Genetic Counseling (NCIT:C15240). NCIT:C15240 is a clinical intervention from the NCI Thesaurus. NCIT:C15240
Genetic counseling is important for recurrence-risk counseling, sex-linked inheritance counseling, and genotype-informed management decisions in DFNX families.
Show evidence (1 reference)
PMID:39272213 SUPPORT Human Clinical
"Analysis of the genotype-phenotype relationship is valuable for X-linked HL precise diagnostics and genetic counseling."
The cohort conclusion directly supports genetic counseling as a management implication of genotype-phenotype analysis.
🔬

Diagnosis

4
Auditory brainstem response and otoacoustic emissions
When AIFM1-related or another auditory neuropathy phenotype is suspected, pair auditory brainstem response (ABR) with otoacoustic emissions (OAE). Present OAE with absent or markedly abnormal ABR supports an auditory-neuropathy phenotype; this pattern should not be generalized to every DFNX subtype.
Results: Present OAE with absent or markedly abnormal ABR supports an auditory-neuropathy phenotype.
Show evidence (2 references)
PMID:10663046 SUPPORT Other
"The combined findings of "normal evoked otoacoustic emissions (EOAE) and absent or markedly disturbed auditory evoked potentials from the brainstem and/or cortex" has been named auditory neuropathy in the English literature."
The PubMed abstract directly supports the OAE-evoked-potential dissociation; it does not rely on a full-text-only cochlear-microphonic statement.
PMID:38016438 SUPPORT Human Clinical
"Its diagnosis is based on presence of otoacoustic emissions and lack of, or abnormal, brainstem auditory evoked potential."
This establishes the core OAE-ABR dissociation used to recognize ANSD.
Internal-auditory-canal MRI for cochlear nerve assessment
MRI may be of value when auditory neuropathy or cochlear nerve deficiency is suspected, particularly in AIFM1-associated disease. Cochlear nerve hypoplasia can localize the lesion and temper expectations for cochlear implantation; the cited evidence does not establish a universal indication.
Results: Cochlear nerve hypoplasia supports a neural lesion and may predict limited cochlear-implant benefit.
Show evidence (1 reference)
PMID:25986071 SUPPORT Human Clinical
"The finding of cochlear nerve hypoplasia in some patients was AIFM1-related ANSD implies that MRI may be of value in localising the site of lesion and suggests that cochlea implantation in these patients may have limited success."
Human imaging data support MRI and the implant-outcome caveat in the AIFM1-associated subset.
High-resolution temporal-bone CT
Temporal-bone CT is the key anatomic study when POU3F4/IP-III is suspected. It distinguishes the absent-modiolus/dilated-IAC pattern from other inner-ear malformations and informs surgery because of the perilymphatic-gusher risk.
Results: Absent cochlear modiolus with dilated lateral internal auditory canal and direct cochlear communication supports IP-III.
Show evidence (1 reference)
PMID:30065609 SUPPORT Other
"Anatomical anomalies of the temporal bone, revealed by Computer-assisted Tomography (CT), include dilatation of the lateral end of the internal acoustic canal, abnormally wide communication between the internal acoustic canal and inner ear compartment and, in some cases, partial hypoplasia of the cochlea"
Review evidence supports CT detection of the characteristic DFNX2/IP-III anatomy.
Molecular genetic testing
Next-generation and third-generation sequencing can identify causal X-chromosome variants in patients with hereditary hearing loss.
Show evidence (2 references)
PMID:39272213 SUPPORT Human Clinical
"We performed a molecular epidemiological investigation of X-linked hereditary HL based on next-generation sequencing and third-generation sequencing in 3646 unrelated patients with HL."
This supports genomic testing as an implemented diagnostic approach in a large X-linked hereditary hearing-loss cohort.
PMID:20301738 SUPPORT Human Clinical
"The diagnosis of PRS deficiency is established in a male proband with suggestive findings and a hemizygous pathogenic variant in PRPS1 identified by molecular genetic testing."
GeneReviews directly supports molecular confirmation for the PRPS1 deficiency continuum represented within DFNX1.
🩻

Imaging Findings

2
Incomplete partition type III on temporal-bone CT
High-resolution temporal-bone CT can show the POU3F4/IP-III pattern: absent modiolus, a widened lateral internal auditory canal with direct communication to the cochlea, and sometimes a thickened stapes footplate. This anatomy distinguishes IP-III from other cochlear partition anomalies and anticipates a perilymphatic gusher risk.
Ct Diagnostic DFNX2
Incomplete partition type III HP:0011373 Human Phenotype Ontology (HP)
Show evidence (1 reference)
PMID:30065609 SUPPORT Other
"Anatomical anomalies of the temporal bone, revealed by Computer-assisted Tomography (CT), include dilatation of the lateral end of the internal acoustic canal, abnormally wide communication between the internal acoustic canal and inner ear compartment and, in some cases, partial hypoplasia of the cochlea"
Review evidence identifies the temporal-bone imaging pattern that distinguishes POU3F4/IP-III anatomy.
Cochlear nerve hypoplasia on internal-auditory-canal MRI
Dedicated internal-auditory-canal MRI may show cochlear nerve hypoplasia in some people with AIFM1-associated auditory neuropathy. This localizes a neural lesion and is clinically important because cochlear implantation may have limited success when the cochlear nerve is hypoplastic.
Mri Diagnostic DFNX5
Cochlear nerve hypoplasia HP:0034585 Human Phenotype Ontology (HP)
Show evidence (1 reference)
PMID:25986071 SUPPORT Human Clinical
"The finding of cochlear nerve hypoplasia in some patients was AIFM1-related ANSD implies that MRI may be of value in localising the site of lesion and suggests that cochlea implantation in these patients may have limited success."
The AIFM1 cohort directly supports MRI localization and the cochlear-nerve-hypoplasia caveat for implant counseling.
🔀

Differential Diagnoses

7

Conditions with similar clinical presentations that must be differentiated from X-linked Nonsyndromic Hearing Loss:

PRPS1 deficiency continuum, including CMTX5 and Arts syndrome MONDO:0100061
Overlapping Features DFNX1, CMTX5, and Arts syndrome are allelic PRPS1-deficiency phenotypic clusters with overlap even within a family. A hearing-loss-predominant presentation should therefore be assessed for peripheral neuropathy, ataxia, optic atrophy, hypotonia, developmental impairment, and recurrent infections rather than assumed to be permanently nonsyndromic.
Distinguishing Features
  • Postlingual progressive hearing loss without systemic findings favors the hearing-loss-predominant DFNX1 cluster.
  • Peripheral neuropathy and optic atrophy favor CMTX5; early hypotonia, ataxia, developmental impairment, and recurrent infections favor Arts syndrome.
  • Residual PRS-I activity and X-inactivation can contribute to intrafamilial and female variability.
Show evidence (1 reference)
PMID:24528855 SUPPORT Human Clinical
"Our findings demonstrate that CMTX5, Arts syndrome and DFN2 are phenotypic clusters on an intrafamilial continuum, including overlapping phenotypes even within individuals."
The family study directly supports treating the PRPS1 conditions as a continuum in differential assessment.
AIFM1 auditory and delayed sensory neuropathy spectrum Not Yet Curated MONDO:0010378
Overlapping Features An initially isolated auditory-neuropathy presentation can precede the sensory neuropathy that defines the broader AIFM1 spectrum. Longitudinal neurologic examination and sensory nerve-conduction studies help avoid a premature nonsyndromic label.
Distinguishing Features
  • Later extremity numbness, unsteadiness, areflexia, or reduced sensory nerve responses favors the broader AIFM1 neuropathy spectrum.
  • Normal early neurologic examination does not exclude AIFM1 because sensory symptoms may appear months or years after auditory neuropathy.
Show evidence (1 reference)
PMID:25986071 SUPPORT Human Clinical
"The phenotype associated with the AUNX1-causing AIFM1 p.R451Q mutation is characterised by childhood-onset ANSD and delayed peripheral sensory neuropathy presenting as extremity numbness, unsteadiness and areflexia."
This directly supports delayed neurologic surveillance as a discriminator.
Other inner-ear malformations versus POU3F4 incomplete partition type III
Overlapping Features Other incomplete-partition patterns, enlarged vestibular aqueduct, cochlear hypoplasia, and cochlear-nerve deficiency can all accompany hearing loss. The specific temporal-bone CT pattern and POU3F4 testing distinguish IP-III.
Distinguishing Features
  • IP-III retains the interscalar septa but lacks the modiolus and has a widened lateral internal auditory canal directly communicating with the cochlea.
  • A perilymphatic gusher risk and POU3F4 variant or upstream deletion further favor IP-III.
  • MRI complements CT when cochlear nerve deficiency rather than a bony partition anomaly is suspected.
Show evidence (1 reference)
PMID:30065609 SUPPORT Other
"Cochlear malformation was shown to consist of a relatively normal outer coat shape, absence of a cochlear modiolus, and a direct inter communication between the IAC and cochlear inner cavity."
The characteristic CT anatomy distinguishes POU3F4/IP-III from other inner-ear malformations.
{ }

Source YAML

click to show 
name: X-linked Nonsyndromic Hearing Loss
creation_date: "2026-05-08T00:00:00Z"
description: >-
  X-linked nonsyndromic hearing loss, also called DFNX, is a genetically
  heterogeneous form of hereditary hearing loss. Six loci (DFNX1-DFNX6) have
  been described, but the gene at DFNX3 remains unidentified. POU3F4 and SMPX
  have definitive ClinGen validity for nonsyndromic genetic hearing loss.
  PRPS1 is definitive only for the lumped PRPS1-deficiency continuum (DFNX1,
  CMTX5, and Arts syndrome), and AIFM1 is definitive for the broader auditory
  and sensory neuropathy spectrum rather than isolated nonsyndromic hearing
  loss. ClinGen classified the COL4A6-hearing loss, X-linked 6 relationship as
  Limited in February 2022. Human family and minigene observations provide
  variant-level evidence. A Col4a6-knockout mouse had normal click-ABR
  thresholds and cochlear morphology, narrowly arguing against simple loss of
  expression as a sufficient mechanism in that model without refuting
  variant-specific human causality. The human gene-disease relationship
  therefore remains unresolved rather than upgraded or broadly refuted. POU3F4
  is the most common DFNX gene and is strongly associated with incomplete
  partition type III inner-ear malformation.
category: Genetic
disease_term:
  preferred_term: X-linked nonsyndromic hearing loss
  term:
    id: MONDO:0019586
    label: X-linked nonsyndromic hearing loss
parents:
- Nonsyndromic Hearing Loss
- X-linked Deafness
synonyms:
- X-linked nonsyndromic deafness
- X-linked non-syndromic sensorineural hearing loss type DFN
- X-linked isolated sensorineural hearing loss type DFN
references:
- reference: PMID:20301607
  title: Genetic Hearing Loss Overview.
  tags:
  - GeneReviews
- reference: PMID:20301738
  title: Phosphoribosylpyrophosphate Synthetase Deficiency.
  tags:
  - GeneReviews
has_subtypes:
- name: DFNX1
  display_name: DFNX1 / PRPS1-related X-linked nonsyndromic hearing loss
  classification: molecular
  subtype_term:
    preferred_term: hearing loss, X-linked 1
    term:
      id: MONDO:0010577
      label: hearing loss, X-linked 1
  description: >-
    PRPS1-related DFNX1 is the hearing-loss-predominant end of the broader
    PRPS1-deficiency continuum rather than a cleanly separable gene-disease
    entity. Reported families include postlingual, bilateral, progressive
    hearing loss, sometimes with mild or subclinical peripheral neuropathy.
  genes:
  - preferred_term: PRPS1
    term:
      id: hgnc:9462
      label: PRPS1
  evidence:
  - reference: PMID:25182139
    reference_title: "The expanding spectrum of PRPS1-associated phenotypes: three novel mutations segregating with X-linked hearing loss and mild peripheral neuropathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Whole-exome sequencing of a single Italian proband affected by
      non-syndromic HL identified a novel missense variant within the PRPS1 gene
      (NM_002764.3:c.337G>T (p.A113S)) segregating with post-lingual, bilateral,
      progressive deafness in the proband's family.
    explanation: >-
      This family study directly links a PRPS1 variant to progressive
      nonsyndromic hearing loss.
- name: DFNX2
  display_name: DFNX2 / DFN3 / POU3F4-related X-linked hearing loss
  classification: molecular
  subtype_term:
    preferred_term: X-linked mixed hearing loss with perilymphatic gusher
    term:
      id: MONDO:0010576
      label: X-linked mixed hearing loss with perilymphatic gusher
  description: >-
    POU3F4-related DFNX2/DFN3 is the most frequent X-linked nonsyndromic
    hearing-loss subtype and is characterized by severe congenital or childhood
    hearing loss with incomplete partition type III inner-ear malformation in
    many affected individuals.
  genes:
  - preferred_term: POU3F4
    term:
      id: hgnc:9217
      label: POU3F4
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      POU3F4 is the gene most commonly associated with X-linked deafness
      (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked
      non-syndromic hearing loss.
    explanation: >-
      This review establishes POU3F4 as the main DFNX gene and links it to the
      DFNX2/DFN3 subtype.
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The clinical features of POU3F4-related hearing loss include a
      pathognomonic malformation of the inner ear defined as incomplete
      partition of the cochlea type 3 (IP-III).
    explanation: >-
      The review directly supports IP-III as the characteristic POU3F4-related
      malformation.
- name: DFNX3
  display_name: DFNX3 / unresolved X-linked nonsyndromic hearing-loss locus
  classification: molecular
  description: >-
    DFNX3 is a mapped X-linked nonsyndromic hearing-loss locus for which no
    causal gene has yet been identified; it accounts for the gap between six
    named DFNX loci and five established genes.
  evidence:
  - reference: PMID:30065609
    reference_title: "X-Linked Sensorineural Hearing Loss: A Literature Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      To date, six loci (DFNX1-6) and five genes (PRPS1 for DFNX1, POU3F4 for
      DFNX2, SMPX for DFNX4, AIFM1 for DFNX5 and COL4A6 for DFNX6) have been
      identified for X-linked non-syndromic hearing loss.
    explanation: >-
      The six-locus/five-gene enumeration documents that DFNX3 remains a locus
      without an identified causal gene.
- name: DFNX4
  display_name: DFNX4 / SMPX-related X-linked nonsyndromic hearing loss
  classification: molecular
  subtype_term:
    preferred_term: hearing loss, X-linked 4
    term:
      id: MONDO:0010238
      label: hearing loss, X-linked 4
  description: >-
    SMPX-related DFNX4 is usually progressive nonsyndromic hearing loss.
    Truncating SMPX variants are associated with DFNX4 auditory phenotypes,
    while nontruncating variants can be associated with non-auditory myopathy
    phenotypes.
  genes:
  - preferred_term: SMPX
    term:
      id: hgnc:11122
      label: SMPX
  evidence:
  - reference: PMID:21549342
    reference_title: "Next-generation sequencing identifies mutations of SMPX, which encodes the small muscle protein, X-linked, as a cause of progressive hearing impairment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a Dutch family with an X-linked postlingual progressive hearing
      impairment, a critical linkage interval was determined to span a region
      of 12.9 Mb flanked by the markers DXS7108 and DXS7110. This interval
      overlaps with the previously described DFNX4 locus and contains 75
      annotated genes. Subsequent next-generation sequencing (NGS) detected one
      variant within the linkage interval, a nonsense mutation in SMPX.
    explanation: >-
      The original DFNX4 study directly establishes the X-linked postlingual
      progressive phenotype.
- name: DFNX5
  display_name: DFNX5 / AIFM1-related X-linked hearing loss
  classification: molecular
  subtype_term:
    preferred_term: X-linked hereditary sensory and autonomic neuropathy with hearing loss
    term:
      id: MONDO:0010378
      label: X-linked hereditary sensory and autonomic neuropathy with hearing loss
  description: >-
    AIFM1-related DFNX5 falls within an X-linked auditory and sensory neuropathy
    spectrum. Auditory neuropathy may precede numbness, unsteadiness, areflexia,
    and abnormal sensory nerve studies by months or years, so an apparently
    isolated auditory presentation requires longitudinal neurologic follow-up.
  genes:
  - preferred_term: AIFM1
    term:
      id: hgnc:8768
      label: AIFM1
  evidence:
  - reference: PMID:25986071
    reference_title: "Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Variants in AIFM1 gene are a common cause of familial and sporadic ANSD
      and provide insight into the expanded spectrum of AIFM1-associated
      diseases.
    explanation: >-
      This Chinese familial-and-sporadic cohort identified AIFM1 variants in an
      auditory-neuropathy phenotype; it does not establish that AIFM1 is a
      common cause of ANSD in every population.
- name: DFNX6
  display_name: DFNX6 / COL4A6-related X-linked hearing loss
  classification: molecular
  subtype_term:
    preferred_term: hearing loss, X-linked 6
    term:
      id: MONDO:0010484
      label: hearing loss, X-linked 6
  description: >-
    DFNX6 is the reported COL4A6-associated X-linked hearing-loss phenotype.
    ClinGen classified the relationship as Limited in February 2022. A family
    and in-vitro minigene result support one splice variant, while another
    reported missense variant remained a variant of uncertain significance.
    Negative mouse-knockout hearing and cochlear-morphology results conflict
    with simple loss of expression being sufficient in that model; they do not
    test the reported human variants or broadly refute COL4A6 causality.
  genes:
  - preferred_term: COL4A6
    term:
      id: hgnc:2208
      label: COL4A6
  evidence:
  - reference: PMID:33840813
    reference_title: "Confirmation of COL4A6 variants in X-linked nonsyndromic hearing loss and its clinical implications."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      An in vitro minigene splicing assay revealed that c.951 + 1 G > T leads
      to skipping of exon 15, strongly suggesting a pathogenic role for this
      variant in the HL phenotype.
    explanation: >-
      The minigene assay is variant-specific in-vitro evidence; it supports
      splice disruption but does not by itself establish the gene-disease
      relationship.
  - reference: PMID:33840813
    reference_title: "Confirmation of COL4A6 variants in X-linked nonsyndromic hearing loss and its clinical implications."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The p.Gly1091Ala variant is classified as a variant of unknown
      significance based on the variant interpretation guidelines.
    explanation: >-
      The study explicitly preserves uncertainty for the reported missense
      variant.
inheritance:
- name: X-linked inheritance
  inheritance_term:
    preferred_term: X-linked inheritance
    term:
      id: HP:0001417
      label: X-linked inheritance
  description: >-
    DFNX comprises hearing-loss loci and genes on the X chromosome. Female
    expression is gene specific: PRPS1 heterozygotes range from unaffected to
    unilateral or bilateral hearing loss and occasional subclinical neuropathy,
    influenced in part by X-inactivation. POU3F4 heterozygotes are usually
    unaffected, although hearing loss has been reported and systematic female
    imaging data are lacking. SMPX-associated hearing loss is often later,
    milder, and less penetrant in females than in males. Female carriers in the
    reported AIFM1 auditory-neuropathy families did not report auditory or
    sensory neuropathy. The few COL4A6 families do not establish reliable
    female penetrance or expressivity.
  expressivity: VARIABLE
  evidence:
  - reference: PMID:30065609
    reference_title: "X-Linked Sensorineural Hearing Loss: A Literature Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      To date, six loci (DFNX1-6) and five genes (PRPS1 for DFNX1, POU3F4 for
      DFNX2, SMPX for DFNX4, AIFM1 for DFNX5 and COL4A6 for DFNX6) have been
      identified for X-linked non-syndromic hearing loss.
    explanation: >-
      The review directly classifies the DFNX loci and genes as X-linked.
  - reference: PMID:25182139
    reference_title: "The expanding spectrum of PRPS1-associated phenotypes: three novel mutations segregating with X-linked hearing loss and mild peripheral neuropathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Female carriers may also be affected by unilateral or bilateral hearing
      impairment.
    explanation: >-
      Human family data support variable auditory expression in PRPS1
      heterozygotes.
  - reference: PMID:30065609
    reference_title: "X-Linked Sensorineural Hearing Loss: A Literature Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Female carriers of a mutation in the DFNX2 usually show no hearing loss
    explanation: >-
      Review evidence supports usually absent but incompletely penetrant female
      expression for POU3F4.
  - reference: PMID:30065609
    reference_title: "X-Linked Sensorineural Hearing Loss: A Literature Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Carrier females present only moderate hearing loss on the high
      frequencies.
    explanation: >-
      Review evidence supports a typically milder SMPX phenotype in females.
  - reference: PMID:25986071
    reference_title: "Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Because female carriers are unaffected, AIFM1 should be considered in
      small pedigrees with apparent autosomal recessive ANSD if X-linked
      inheritance cannot be excluded.
    explanation: >-
      This describes female nonpenetrance in the reported AIFM1 cohort, without
      assuming it for every AIFM1 variant or phenotype.
  - reference: PMID:20301738
    reference_title: "Phosphoribosylpyrophosphate Synthetase Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      PRS deficiency is inherited in an X-linked manner. If the mother of the
      proband has a PRPS1 pathogenic variant, the chance of transmitting it in
      each pregnancy is 50%
    explanation: >-
      GeneReviews provides the X-linked transmission risk for the PRPS1
      deficiency continuum; expressivity in heterozygous females remains
      gene- and variant-specific.
pathophysiology:
- name: PRPS1 enzymatic activity deficiency
  biological_scale: MOLECULAR
  description: >-
    DFNX1 missense variants reduce phosphoribosyl pyrophosphate synthetase 1
    activity. The available human biochemical evidence establishes reduced
    enzyme activity but does not yet resolve why partial PRPS1 deficiency is
    selectively expressed as hearing loss in milder cases.
  genes:
  - preferred_term: PRPS1
    term:
      id: hgnc:9462
      label: PRPS1
  evidence:
  - reference: PMID:25182139
    reference_title: "The expanding spectrum of PRPS1-associated phenotypes: three novel mutations segregating with X-linked hearing loss and mild peripheral neuropathy."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      All three variants result in a marked reduction (>60%) of the PRS-I
      activity in the patients' erythrocytes, with c.343A>G (p.M115V) and
      c.925G>T (p.V309F) affecting more severely the enzyme function.
    explanation: >-
      Biochemical assays on patient erythrocytes support reduced PRS-I activity
      as the molecular consequence of the DFNX1 variants.
  downstream:
  - target: Progressive sensorineural hearing impairment
    description: >-
      Partial PRPS1 deficiency is associated with postlingual bilateral
      progressive hearing loss in DFNX1 families.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:25182139
      reference_title: "The expanding spectrum of PRPS1-associated phenotypes: three novel mutations segregating with X-linked hearing loss and mild peripheral neuropathy."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Whole-exome sequencing of a single Italian proband affected by
        non-syndromic HL identified a novel missense variant within the PRPS1
        gene (NM_002764.3:c.337G>T (p.A113S)) segregating with post-lingual,
        bilateral, progressive deafness in the proband's family.
      explanation: >-
        Segregation in a human family directly connects PRPS1 variation with
        the progressive hearing phenotype, while the intermediate steps remain
        unresolved.
- name: POU3F4-related inner ear developmental malformation
  biological_scale: TISSUE
  description: >-
    POU3F4 encodes a POU-family transcription factor required for middle and
    inner ear development. POU3F4 defects can disrupt inner-ear morphogenesis,
    producing incomplete partition type III and predisposing to perilymphatic
    gusher during otologic surgery.
  genes:
  - preferred_term: POU3F4
    term:
      id: hgnc:9217
      label: POU3F4
  biological_processes:
  - preferred_term: inner ear morphogenesis
    modifier: ABNORMAL
    term:
      id: GO:0042472
      label: inner ear morphogenesis
  - preferred_term: regulation of DNA-templated transcription
    modifier: ABNORMAL
    term:
      id: GO:0006355
      label: regulation of DNA-templated transcription
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      This gene codes for a transcription factor of the POU family that plays a
      major role in the development of the middle and inner ear.
    explanation: >-
      The review supports the developmental transcription-factor mechanism for
      POU3F4-related DFNX.
  downstream:
  - target: Incomplete partition type III
    description: >-
      Developmental disruption causes the characteristic IP-III inner-ear
      malformation.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:37371790
      reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        The clinical features of POU3F4-related hearing loss include a
        pathognomonic malformation of the inner ear defined as incomplete
        partition of the cochlea type 3 (IP-III).
      explanation: >-
        The review directly links POU3F4-related hearing loss to IP-III.
  - target: Sensorineural hearing impairment
    description: >-
      POU3F4-related developmental disruption is associated with both IP-III
      and hearing impairment, but the evidence does not isolate IP-III itself
      as the sole causal route to the auditory deficit.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:37371790
      reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
      supports: SUPPORT
      evidence_source: OTHER
      snippet: >-
        The clinical features of POU3F4-related hearing loss include a
        pathognomonic malformation of the inner ear defined as incomplete
        partition of the cochlea type 3 (IP-III).
      explanation: >-
        The review links POU3F4-related hearing loss and IP-III, supporting a
        conservative connection while leaving the intervening mechanism and
        the malformation's independent contribution unresolved.
- name: SMPX-related hair-cell mechanotransduction defect
  biological_scale: CELLULAR
  description: >-
    SMPX encodes a cytoskeleton-associated protein expressed in inner-ear hair
    cells. Model-organism evidence supports a role in hair-cell differentiation,
    stereociliary and kinociliary integrity, and mechanotransduction, providing
    a cellular mechanism for progressive DFNX4 hearing loss.
  genes:
  - preferred_term: SMPX
    term:
      id: hgnc:11122
      label: SMPX
  cell_types:
  - preferred_term: Auditory hair cell
    term:
      id: CL:0000202
      label: auditory hair cell
  biological_processes:
  - preferred_term: detection of mechanical stimulus involved in sensory perception
    modifier: DECREASED
    term:
      id: GO:0050974
      label: detection of mechanical stimulus involved in sensory perception
  - preferred_term: cell projection organization
    modifier: ABNORMAL
    term:
      id: GO:0030030
      label: cell projection organization
  evidence:
  - reference: PMID:38570547
    reference_title: "Differentiation and functioning of the lateral line organ in zebrafish require Smpx activity."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      The small muscle protein, X-linked (SMPX) gene encodes a
      cytoskeleton-associated protein, highly expressed in the inner ear hair
      cells (HCs), possibly regulating auditory function.
    explanation: >-
      The abstract supports SMPX expression in inner-ear hair cells and its
      likely auditory role.
  - reference: PMID:38570547
    reference_title: "Differentiation and functioning of the lateral line organ in zebrafish require Smpx activity."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Such phenotypes were associated with a significant reduction in the
      mechanotransduction activity of the neuromast HCs
    explanation: >-
      Zebrafish loss-of-function evidence supports reduced mechanotransduction
      as a cellular consequence of SMPX deficiency.
  - reference: PMID:34722533
    reference_title: "SMPX Deficiency Causes Stereocilia Degeneration and Progressive Hearing Loss in CBA/CaJ Mice."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Through morphological analyses of mice cochleas, we found the hair cell
      bundles progressively degenerated from the shortest row. Cellular edema
      occurred at the end phase of stereocilia degeneration, followed by cell
      death.
    explanation: >-
      Mouse data independently support progressive stereocilia degeneration and
      hair-cell death after Smpx loss.
  downstream:
  - target: Progressive sensorineural hearing impairment
    description: >-
      Reduced hair-cell mechanotransduction provides a cellular route from SMPX
      deficiency to progressive sensorineural hearing impairment.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:38570547
      reference_title: "Differentiation and functioning of the lateral line organ in zebrafish require Smpx activity."
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        Such phenotypes were associated with a significant reduction in the
        mechanotransduction activity of the neuromast HCs
      explanation: >-
        Model-organism data connect SMPX deficiency with reduced hair-cell
        mechanotransduction, supporting the edge to progressive hearing
        impairment.
    - reference: PMID:21549342
      reference_title: "Next-generation sequencing identifies mutations of SMPX, which encodes the small muscle protein, X-linked, as a cause of progressive hearing impairment."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        In a Dutch family with an X-linked postlingual progressive hearing
        impairment, a critical linkage interval was determined to span a region
        of 12.9 Mb flanked by the markers DXS7108 and DXS7110.
      explanation: >-
        Human family evidence independently supports the progressive hearing
        endpoint of the model-derived mechanistic edge.
- name: AIFM1-related auditory signal transmission defect
  biological_scale: TISSUE
  description: >-
    The reported AIFM1 phenotype is an auditory and sensory neuropathy spectrum
    in which transmission from the inner ear to the auditory nerve and
    brainstem is distorted. The cited human cohort does not establish a single
    cellular lesion in every affected individual or isolate hearing loss from
    the delayed neurologic phenotype.
  genes:
  - preferred_term: AIFM1
    term:
      id: hgnc:8768
      label: AIFM1
  evidence:
  - reference: PMID:25986071
    reference_title: "Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Auditory neuropathy spectrum disorder (ANSD) is a form of hearing loss in
      which auditory signal transmission from the inner ear to the auditory
      nerve and brain stem is distorted, giving rise to speech perception
      difficulties beyond that expected for the observed degree of hearing
      loss.
    explanation: >-
      The clinical study defines the transmission defect represented by this
      node.
  downstream:
  - target: Auditory neuropathy spectrum disorder
    description: >-
      AIFM1 variants segregated with auditory and peripheral sensory neuropathy
      in several families and were also identified in sporadic ANSD cases in a
      Chinese cohort.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:25986071
      reference_title: "Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Variants in AIFM1 gene are a common cause of familial and sporadic ANSD
        and provide insight into the expanded spectrum of AIFM1-associated
        diseases.
      explanation: >-
        The study supports the AIFM1-associated auditory-neuropathy phenotype
        in the studied cohort without implying population-independent frequency
        or an isolated nonsyndromic boundary.
- name: Candidate COL4A6-associated cochlear basement-membrane involvement
  biological_scale: TISSUE
  mechanism_confidence: HYPOTHETICAL
  description: >-
    COL4A6 encodes the alpha-6 chain of type IV collagen in basement membranes.
    The ClinGen assertion classifies the DFNX6 relationship as Limited. Human
    segregation and a variant-specific minigene assay provide candidate
    support, while expression in animal inner ears supports biological
    plausibility. In conflict, Col4a6-knockout mice had normal click-ABR
    thresholds and cochlear morphology. That result narrowly argues against
    simple loss of expression being sufficient in the mouse model, but does not
    test allele-specific human effects or establish a general cochlear
    mechanism.
  genes:
  - preferred_term: COL4A6
    term:
      id: hgnc:2208
      label: COL4A6
  evidence:
  - reference: PMID:23714752
    reference_title: "Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Next-generation sequencing and subsequent segregation analysis detected a
      missense mutation (c.1771G>A, p.Gly591Ser) in the type IV collagen gene
      COL4A6 in all affected family members.
    explanation: >-
      Human segregation in the original family supports, but does not by itself
      establish, the COL4A6 association.
  - reference: PMID:23714752
    reference_title: "Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6."
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In situ hybridization and immunostaining demonstrated expression of the
      COL4A6 homologs in the otic vesicle of the zebrafish and in the murine
      inner ear, supporting its role in normal ear development and function.
    explanation: >-
      Cross-species expression supplies model-organism support for an inner-ear
      role without overstating the unresolved mechanism.
  downstream:
  - target: Sensorineural hearing impairment
    description: >-
      Reported human families support a possible COL4A6-hearing-impairment
      association, but the Limited ClinGen classification leaves gene-level
      causality and the intervening mechanism unresolved.
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
    evidence:
    - reference: PMID:23714752
      reference_title: "Novel form of X-linked nonsyndromic hearing loss with cochlear malformation caused by a mutation in the type IV collagen gene COL4A6."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Next-generation sequencing and subsequent segregation analysis detected a
        missense mutation (c.1771G>A, p.Gly591Ser) in the type IV collagen gene
        COL4A6 in all affected family members.
      explanation: >-
        Segregation supports a candidate association but is insufficient to
        establish gene-level causality or the intervening mechanism.
phenotypes:
- category: Clinical
  name: Sensorineural hearing impairment
  description: >-
    Sensorineural hearing impairment is directly documented in DFNX1; the
    auditory phenotype is not uniform across every DFNX subtype.
  phenotype_term:
    preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:27886419
    reference_title: "Functional characterization of a novel loss-of-function mutation of PRPS1 related to early-onset progressive nonsyndromic hearing loss in Koreans (DFNX1): Potential implications on future therapeutic intervention."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A strong candidate variant (p.A82P) of PRPS1 is co-segregated with SNHL in
      X-linked recessive inheritance from one Korean multiplex SNHL family.
    explanation: >-
      The family study directly supports sensorineural hearing loss in DFNX1.
- category: Clinical
  name: Progressive sensorineural hearing impairment
  description: >-
    Progressive sensorineural hearing loss is especially emphasized for PRPS1
    and SMPX-related DFNX subtypes.
  phenotype_term:
    preferred_term: Progressive sensorineural hearing impairment
    term:
      id: HP:0000408
      label: Progressive sensorineural hearing impairment
  evidence:
  - reference: PMID:25182139
    reference_title: "The expanding spectrum of PRPS1-associated phenotypes: three novel mutations segregating with X-linked hearing loss and mild peripheral neuropathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Whole-exome sequencing of a single Italian proband affected by
      non-syndromic HL identified a novel missense variant within the PRPS1 gene
      (NM_002764.3:c.337G>T (p.A113S)) segregating with post-lingual, bilateral,
      progressive deafness in the proband's family.
    explanation: >-
      The family study directly supports progressive hearing loss in DFNX1.
  - reference: PMID:21549342
    reference_title: "Next-generation sequencing identifies mutations of SMPX, which encodes the small muscle protein, X-linked, as a cause of progressive hearing impairment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In a Dutch family with an X-linked postlingual progressive hearing
      impairment, a critical linkage interval was determined to span a region
      of 12.9 Mb flanked by the markers DXS7108 and DXS7110.
    explanation: >-
      The original DFNX4 study directly supports postlingual progressive
      hearing loss.
- category: Clinical
  name: Auditory neuropathy spectrum disorder
  description: >-
    The reported AIFM1-associated DFNX5 phenotype includes auditory neuropathy,
    with distorted transmission from the inner ear to the auditory nerve and
    brainstem; delayed sensory neuropathy means it should not be assumed to
    remain nonsyndromic. No exact HPO term was found locally, so the specific
    phenotype is retained without a broader substitute.
  subtype: DFNX5
  evidence:
  - reference: PMID:25986071
    reference_title: "Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Variants in AIFM1 gene are a common cause of familial and sporadic ANSD
      and provide insight into the expanded spectrum of AIFM1-associated
      diseases.
    explanation: >-
      This supports ANSD within the reported AIFM1-associated DFNX5 cohort;
      it does not establish AIFM1 as a common cause across unselected ANSD.
- category: Clinical
  name: Incomplete partition type III
  description: >-
    POU3F4-related DFNX2/DFN3 is associated with incomplete partition type III,
    a characteristic inner-ear malformation that affects surgical planning.
  subtype: DFNX2
  phenotype_term:
    preferred_term: Incomplete partition type III
    term:
      id: HP:0011373
      label: Incomplete partition of the cochlea
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The clinical features of POU3F4-related hearing loss include a
      pathognomonic malformation of the inner ear defined as incomplete
      partition of the cochlea type 3 (IP-III).
    explanation: >-
      The review directly supports IP-III as the characteristic POU3F4-related
      malformation.
  - reference: PMID:38498189
    reference_title: "Research progress on incomplete partition type 3 inner ear malformation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Mutations in the POU3F4 gene emerge as the principal pathogenic
      contributors to IP-III anomalies
    explanation: >-
      The IP-III review independently supports POU3F4 as the principal genetic
      contributor to this malformation.
- category: Clinical
  name: Perilymphatic gusher during stapedectomy
  description: >-
    POU3F4-related DFNX2 can include perilymphatic gusher during otologic
    surgery, probably reflecting incomplete separation between the cochlea and
    internal auditory canal. No exact HPO term was identified locally, so this
    is retained as a named clinical phenotype without a broad substitute term.
  subtype: DFNX2
  evidence:
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Often, a perilymphatic gusher is observed upon stapedectomy during
      surgery, possibly as a consequence of an incomplete separation of the
      cochlea from the internal auditory canal.
    explanation: >-
      The POU3F4 review directly supports perilymphatic gusher as a
      DFNX2-relevant surgical phenotype.
genetic:
- name: PRPS1 pathogenic variants
  gene_term:
    preferred_term: PRPS1
    term:
      id: hgnc:9462
      label: PRPS1
  presence: Pathogenic
  association: Definitive ClinGen validity for the lumped PRPS1 deficiency disorder, not for isolated DFNX1 alone
  relationship_type: CAUSATIVE
  subtype: DFNX1
  evidence:
  - reference: CGGV:assertion_9416f6e2-8de3-48b0-9a1c-9bd11a59315c-2020-02-14T170000.000Z
    reference_title: "PRPS1 / PRPS1 deficiency disorder (Definitive)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "PRPS1 | HGNC:9462 | PRPS1 deficiency disorder | MONDO:0100061 | XL | Definitive"
    explanation: >-
      ClinGen's definitive assertion explicitly concerns the lumped PRPS1
      deficiency disorder that includes nonsyndromic and syndromic phenotypes.
  - reference: PMID:25182139
    reference_title: "The expanding spectrum of PRPS1-associated phenotypes: three novel mutations segregating with X-linked hearing loss and mild peripheral neuropathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Defects in this gene, encoding the phosphoribosyl pyrophosphate synthetase
      1 (PRS-I) enzyme, determine either X-linked syndromic conditions associated
      with hearing impairment (eg, Arts syndrome and Charcot-Marie-Tooth
      neuropathy type X-5) or non-syndromic HL (DFNX1).
    explanation: >-
      The study directly identifies PRPS1 defects as the cause of DFNX1.
- name: POU3F4 pathogenic variants
  gene_term:
    preferred_term: POU3F4
    term:
      id: hgnc:9217
      label: POU3F4
  presence: Pathogenic
  association: Definitive ClinGen gene-disease validity for nonsyndromic genetic hearing loss
  relationship_type: CAUSATIVE
  subtype: DFNX2
  case_fractions:
  - population: Chinese X-linked hereditary hearing-loss cohort
    case_fraction_percent: 59.0
    cohort_size: 22
    notes: POU3F4 variants accounted for 13 of 22 X-linked diagnoses in this cohort.
    evidence:
    - reference: PMID:39272213
      reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        the aggregate contribution of HL caused by genes on the X chromosome in
        this cohort was ~ 1.14% (22/1922), and POU3F4 variants caused ~ 59%
        (13/22) of these cases.
      explanation: >-
        This cohort-specific fraction quantifies POU3F4 among molecularly
        diagnosed X-linked cases and is not a population prevalence estimate.
  evidence:
  - reference: CGGV:assertion_4ab4f4a3-757d-4de3-90e7-42a229c360a0-2018-01-05T170000.000Z
    reference_title: "POU3F4 / nonsyndromic genetic hearing loss (Definitive)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "POU3F4 | HGNC:9217 | nonsyndromic genetic hearing loss | MONDO:0019497 | XL | Definitive"
    explanation: >-
      ClinGen directly classifies the POU3F4-nonsyndromic hearing-loss
      relationship as definitive.
  - reference: PMID:37371790
    reference_title: "Clinical and Molecular Aspects Associated with Defects in the Transcription Factor POU3F4: A Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      POU3F4 is the gene most commonly associated with X-linked deafness
      (DFNX2, DFN3) and accounts for about 50% of the cases of X-linked
      non-syndromic hearing loss.
    explanation: >-
      Review-level evidence supports POU3F4 as the most common DFNX gene.
- name: SMPX pathogenic variants
  gene_term:
    preferred_term: SMPX
    term:
      id: hgnc:11122
      label: SMPX
  presence: Pathogenic
  association: Definitive ClinGen gene-disease validity for nonsyndromic genetic hearing loss
  relationship_type: CAUSATIVE
  subtype: DFNX4
  evidence:
  - reference: CGGV:assertion_29773bee-1f13-43f6-bda0-c5a646efccd7-2017-09-12T160000.000Z
    reference_title: "SMPX / nonsyndromic genetic hearing loss (Definitive)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "SMPX | HGNC:11122 | nonsyndromic genetic hearing loss | MONDO:0019497 | XL | Definitive"
    explanation: >-
      ClinGen directly classifies the SMPX-nonsyndromic hearing-loss
      relationship as definitive.
  - reference: PMID:21549342
    reference_title: "Next-generation sequencing identifies mutations of SMPX, which encodes the small muscle protein, X-linked, as a cause of progressive hearing impairment."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Subsequent next-generation sequencing (NGS) detected one variant within
      the linkage interval, a nonsense mutation in SMPX.
    explanation: >-
      The original DFNX4 linkage study identifies a truncating SMPX variant.
- name: AIFM1 pathogenic variants
  gene_term:
    preferred_term: AIFM1
    term:
      id: hgnc:8768
      label: AIFM1
  presence: Pathogenic
  association: Definitive ClinGen validity for the broader X-linked auditory and sensory neuropathy spectrum, not isolated nonsyndromic hearing loss
  relationship_type: CAUSATIVE
  subtype: DFNX5
  evidence:
  - reference: CGGV:assertion_a7afc3bb-7fce-45fd-a275-87277e22b1eb-2025-08-26T160000.000Z
    reference_title: "AIFM1 / X-linked hereditary sensory and autonomic neuropathy with hearing loss (Definitive)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "AIFM1 | HGNC:8768 | X-linked hereditary sensory and autonomic neuropathy with hearing loss | MONDO:0010378 | XL | Definitive"
    explanation: >-
      ClinGen's definitive assertion is for the lumped auditory and sensory
      neuropathy spectrum rather than isolated nonsyndromic hearing loss.
  - reference: PMID:25986071
    reference_title: "Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified two missense mutations in AIFM1 in these families:
      c.1352G>A (p.R451Q) in the AUNX1 family and c.1030C>T (p.L344F) in the
      second ANSD family.
    explanation: >-
      Family-based sequencing directly identifies AIFM1 variants in DFNX5-like
      auditory neuropathy pedigrees.
- name: Reported COL4A6 variants
  gene_term:
    preferred_term: COL4A6
    term:
      id: hgnc:2208
      label: COL4A6
  presence: Reported
  association: Limited ClinGen gene-disease validity; family and minigene observations provide variant-level partial evidence without establishing gene-level causality
  subtype: DFNX6
  evidence:
  - reference: CGGV:assertion_d026ef00-c6f3-4aa8-a61a-b354b68fe043-2022-02-16T170000.000Z
    reference_title: "COL4A6 / hearing loss, X-linked 6 (Limited)"
    supports: SUPPORT
    evidence_source: OTHER
    snippet: "COL4A6 | HGNC:2208 | hearing loss, X-linked 6 | MONDO:0010484 | XL | Limited"
    explanation: >-
      ClinGen retained Limited validity for COL4A6-related DFNX6 in February
      2022; this is the governing expert-panel classification.
  - reference: PMID:33840813
    reference_title: "Confirmation of COL4A6 variants in X-linked nonsyndromic hearing loss and its clinical implications."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      An in vitro minigene splicing assay revealed that c.951 + 1 G > T leads
      to skipping of exon 15, strongly suggesting a pathogenic role for this
      variant in the HL phenotype.
    explanation: >-
      The minigene assay supports splice disruption for one variant but does not
      independently establish categorical gene-level causation; the other
      reported missense variant remained uncertain.
imaging_findings:
- name: Incomplete partition type III on temporal-bone CT
  modality: CT
  description: >-
    High-resolution temporal-bone CT can show the POU3F4/IP-III pattern: absent
    modiolus, a widened lateral internal auditory canal with direct
    communication to the cochlea, and sometimes a thickened stapes footplate.
    This anatomy distinguishes IP-III from other cochlear partition anomalies
    and anticipates a perilymphatic gusher risk.
  phenotype_term:
    preferred_term: Incomplete partition type III
    term:
      id: HP:0011373
      label: Incomplete partition of the cochlea
  diagnostic: true
  subtype: DFNX2
  evidence:
  - reference: PMID:30065609
    reference_title: "X-Linked Sensorineural Hearing Loss: A Literature Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Anatomical anomalies of the temporal bone, revealed by Computer-assisted
      Tomography (CT), include dilatation of the lateral end of the internal
      acoustic canal, abnormally wide communication between the internal
      acoustic canal and inner ear compartment and, in some cases, partial
      hypoplasia of the cochlea
    explanation: >-
      Review evidence identifies the temporal-bone imaging pattern that
      distinguishes POU3F4/IP-III anatomy.
- name: Cochlear nerve hypoplasia on internal-auditory-canal MRI
  modality: MRI
  description: >-
    Dedicated internal-auditory-canal MRI may show cochlear nerve hypoplasia in
    some people with AIFM1-associated auditory neuropathy. This localizes a
    neural lesion and is clinically important because cochlear implantation may
    have limited success when the cochlear nerve is hypoplastic.
  phenotype_term:
    preferred_term: Cochlear nerve hypoplasia
    term:
      id: HP:0034585
      label: Cochlear nerve hypoplasia
  diagnostic: true
  subtype: DFNX5
  evidence:
  - reference: PMID:25986071
    reference_title: "Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The finding of cochlear nerve hypoplasia in some patients was
      AIFM1-related ANSD implies that MRI may be of value in localising the site
      of lesion and suggests that cochlea implantation in these patients may
      have limited success.
    explanation: >-
      The AIFM1 cohort directly supports MRI localization and the
      cochlear-nerve-hypoplasia caveat for implant counseling.
diagnosis:
- name: Auditory brainstem response and otoacoustic emissions
  description: >-
    When AIFM1-related or another auditory neuropathy phenotype is suspected,
    pair auditory brainstem response (ABR) with otoacoustic emissions (OAE).
    Present OAE with absent or markedly abnormal ABR supports an
    auditory-neuropathy phenotype; this pattern should not be generalized to
    every DFNX subtype.
  results: Present OAE with absent or markedly abnormal ABR supports an auditory-neuropathy phenotype.
  evidence:
  - reference: PMID:10663046
    reference_title: "[Otoacoustic emissions, auditory evoked potentials, pure tone thresholds and speech intelligibility in cases of auditory neuropathy]."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The combined findings of "normal evoked otoacoustic emissions (EOAE) and
      absent or markedly disturbed auditory evoked potentials from the
      brainstem and/or cortex" has been named auditory neuropathy in the
      English literature.
    explanation: >-
      The PubMed abstract directly supports the OAE-evoked-potential
      dissociation; it does not rely on a full-text-only cochlear-microphonic
      statement.
  - reference: PMID:38016438
    reference_title: "Cochlear Implantation in Children with Auditory Neuropathy: Meta-Analysis."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Its diagnosis is based on presence of otoacoustic emissions and lack of,
      or abnormal, brainstem auditory evoked potential.
    explanation: >-
      This establishes the core OAE-ABR dissociation used to recognize ANSD.
- name: Internal-auditory-canal MRI for cochlear nerve assessment
  description: >-
    MRI may be of value when auditory neuropathy or cochlear nerve deficiency
    is suspected, particularly in AIFM1-associated disease. Cochlear nerve
    hypoplasia can localize the lesion and temper expectations for cochlear
    implantation; the cited evidence does not establish a universal indication.
  results: Cochlear nerve hypoplasia supports a neural lesion and may predict limited cochlear-implant benefit.
  evidence:
  - reference: PMID:25986071
    reference_title: "Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The finding of cochlear nerve hypoplasia in some patients was
      AIFM1-related ANSD implies that MRI may be of value in localising the site
      of lesion and suggests that cochlea implantation in these patients may
      have limited success.
    explanation: >-
      Human imaging data support MRI and the implant-outcome caveat in the
      AIFM1-associated subset.
- name: High-resolution temporal-bone CT
  description: >-
    Temporal-bone CT is the key anatomic study when POU3F4/IP-III is suspected.
    It distinguishes the absent-modiolus/dilated-IAC pattern from other inner-ear
    malformations and informs surgery because of the perilymphatic-gusher risk.
  results: Absent cochlear modiolus with dilated lateral internal auditory canal and direct cochlear communication supports IP-III.
  evidence:
  - reference: PMID:30065609
    reference_title: "X-Linked Sensorineural Hearing Loss: A Literature Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Anatomical anomalies of the temporal bone, revealed by Computer-assisted
      Tomography (CT), include dilatation of the lateral end of the internal
      acoustic canal, abnormally wide communication between the internal
      acoustic canal and inner ear compartment and, in some cases, partial
      hypoplasia of the cochlea
    explanation: >-
      Review evidence supports CT detection of the characteristic DFNX2/IP-III
      anatomy.
- name: Molecular genetic testing
  description: >-
    Next-generation and third-generation sequencing can identify causal
    X-chromosome variants in patients with hereditary hearing loss.
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We performed a molecular epidemiological investigation of X-linked
      hereditary HL based on next-generation sequencing and third-generation
      sequencing in 3646 unrelated patients with HL.
    explanation: >-
      This supports genomic testing as an implemented diagnostic approach in a
      large X-linked hereditary hearing-loss cohort.
  - reference: PMID:20301738
    reference_title: "Phosphoribosylpyrophosphate Synthetase Deficiency."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The diagnosis of PRS deficiency is established in a male proband with
      suggestive findings and a hemizygous pathogenic variant in PRPS1
      identified by molecular genetic testing.
    explanation: >-
      GeneReviews directly supports molecular confirmation for the PRPS1
      deficiency continuum represented within DFNX1.
differential_diagnoses:
- name: PRPS1 deficiency continuum, including CMTX5 and Arts syndrome
  disease_term:
    preferred_term: PRPS1 deficiency disorder
    term:
      id: MONDO:0100061
      label: PRPS1 deficiency disorder
  description: >-
    DFNX1, CMTX5, and Arts syndrome are allelic PRPS1-deficiency phenotypic
    clusters with overlap even within a family. A hearing-loss-predominant
    presentation should therefore be assessed for peripheral neuropathy,
    ataxia, optic atrophy, hypotonia, developmental impairment, and recurrent
    infections rather than assumed to be permanently nonsyndromic.
  distinguishing_features:
  - Postlingual progressive hearing loss without systemic findings favors the hearing-loss-predominant DFNX1 cluster.
  - Peripheral neuropathy and optic atrophy favor CMTX5; early hypotonia, ataxia, developmental impairment, and recurrent infections favor Arts syndrome.
  - Residual PRS-I activity and X-inactivation can contribute to intrafamilial and female variability.
  evidence:
  - reference: PMID:24528855
    reference_title: "X-linked Charcot-Marie-Tooth disease, Arts syndrome, and prelingual non-syndromic deafness form a disease continuum: evidence from a family with a novel PRPS1 mutation."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Our findings demonstrate that CMTX5, Arts syndrome and DFN2 are
      phenotypic clusters on an intrafamilial continuum, including overlapping
      phenotypes even within individuals.
    explanation: >-
      The family study directly supports treating the PRPS1 conditions as a
      continuum in differential assessment.
- name: AIFM1 auditory and delayed sensory neuropathy spectrum
  disease_term:
    preferred_term: X-linked hereditary sensory and autonomic neuropathy with hearing loss
    term:
      id: MONDO:0010378
      label: X-linked hereditary sensory and autonomic neuropathy with hearing loss
  description: >-
    An initially isolated auditory-neuropathy presentation can precede the
    sensory neuropathy that defines the broader AIFM1 spectrum. Longitudinal
    neurologic examination and sensory nerve-conduction studies help avoid a
    premature nonsyndromic label.
  distinguishing_features:
  - Later extremity numbness, unsteadiness, areflexia, or reduced sensory nerve responses favors the broader AIFM1 neuropathy spectrum.
  - Normal early neurologic examination does not exclude AIFM1 because sensory symptoms may appear months or years after auditory neuropathy.
  evidence:
  - reference: PMID:25986071
    reference_title: "Mutations in apoptosis-inducing factor cause X-linked recessive auditory neuropathy spectrum disorder."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The phenotype associated with the AUNX1-causing AIFM1 p.R451Q mutation is
      characterised by childhood-onset ANSD and delayed peripheral sensory
      neuropathy presenting as extremity numbness, unsteadiness and areflexia.
    explanation: >-
      This directly supports delayed neurologic surveillance as a discriminator.
- name: TIMM8A-related Mohr-Tranebjaerg syndrome
  description: >-
    TIMM8A-related deafness-dystonia-optic neuronopathy (Mohr-Tranebjaerg
    syndrome) is a rare X-linked neurodegenerative disorder characterized by
    early-onset deafness, dystonia, and other neurologic manifestations. It is a
    syndromic differential when those features accompany an X-linked auditory
    presentation.
  distinguishing_features:
  - Early-onset deafness with dystonia or other neurologic manifestations favors Mohr-Tranebjaerg syndrome over isolated DFNX.
  evidence:
  - reference: PMID:31903733
    reference_title: "Functional analysis of a novel mutation in the TIMM8A gene that causes deafness-dystonia-optic neuronopathy syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The rare, X-linked neurodegenerative disorder, Mohr-Tranebjaerg syndrome
    explanation: >-
      The PubMed abstract directly identifies Mohr-Tranebjaerg syndrome as a
      rare X-linked neurodegenerative disorder.
  - reference: PMID:31903733
    reference_title: "Functional analysis of a novel mutation in the TIMM8A gene that causes deafness-dystonia-optic neuronopathy syndrome."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      syndrome), is caused by mutations in the TIMM8A gene. DDON syndrome is
      characterized by dystonia, early-onset deafness, and various other
      neurological manifestations.
    explanation: >-
      The PubMed abstract directly supports the TIMM8A basis and the
      deafness-dystonia-neurologic feature combination.
- name: NDP-related Norrie disease
  description: >-
    Norrie disease is an X-linked NDP-related retinopathy that can include
    sensorineural hearing loss. Retinal fibrovascular changes evident at birth
    and extraocular findings distinguish it from a primary nonsyndromic DFNX
    presentation.
  distinguishing_features:
  - Bilateral elevated retrolental masses and incomplete foveal development strongly favor Norrie disease.
  - Cognitive, behavioral, seizure, or peripheral vascular manifestations may accompany the retinal and auditory phenotype.
  - In a male proband with suggestive findings, molecular identification of a hemizygous NDP pathogenic variant establishes an NDP-related retinopathy.
  evidence:
  - reference: PMID:20301506
    reference_title: "NDP-Related Retinopathies."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      NDP-related retinopathies typically involve bilateral and symmetric
      fibrovascular changes of the retina that are evident at birth and usually
      progress through childhood or adolescence to cause varying degrees of
      visual impairment.
    explanation: >-
      The GeneReviews PubMed record directly supports the bilateral retinal
      fibrovascular changes and their presence at birth.
  - reference: PMID:20301506
    reference_title: "NDP-Related Retinopathies."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The eye findings of Norrie disease, the first described and best
      characterized of these disorders, are typically bilateral grayish-yellow,
      glistening, elevated retrolental masses composed of immature retinal cells
      usually visible through clear lenses; foveal development is always
      incomplete.
    explanation: >-
      The GeneReviews PubMed record directly supports the retrolental-mass and
      incomplete-foveal-development discriminators.
  - reference: PMID:20301506
    reference_title: "NDP-Related Retinopathies."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Norrie disease is the only NDP-related retinopathy with associated
      extraocular findings, which can variably include cognitive disability,
      mental health and behavior disorders, seizures, sensorineural hearing
      loss, and peripheral vascular disease.
    explanation: >-
      GeneReviews directly sources sensorineural hearing loss and the
      syndromic features that distinguish Norrie disease from isolated DFNX.
  - reference: PMID:20301506
    reference_title: "NDP-Related Retinopathies."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      The diagnosis of an NDP-related retinopathy, an X-linked disorder, is
      established in a male proband with suggestive clinical findings by
      identification on molecular genetic testing of a hemizygous pathogenic
      variant in NDP
    explanation: >-
      The GeneReviews PubMed record directly supports the hemizygous-NDP
      diagnostic statement for an affected male with suggestive findings.
- name: COL4A5-related Alport syndrome and COL4A5-COL4A6 contiguous deletions
  disease_term:
    preferred_term: Alport syndrome
    term:
      id: MONDO:0018965
      label: Alport syndrome
  description: >-
    X-linked Alport syndrome can include sensorineural hearing loss, and
    contiguous deletions extending from COL4A5 into COL4A6 can add diffuse
    leiomyomatosis. These diagnoses must be separated from a candidate isolated
    COL4A6/DFNX6 association by renal, ocular, smooth-muscle, and molecular
    findings.
  distinguishing_features:
  - Microhematuria, proteinuria, kidney insufficiency, anterior lenticonus, or maculopathy favors Alport syndrome.
  - Esophageal, tracheobronchial, or genital leiomyomatosis suggests a COL4A5-COL4A6 contiguous deletion.
  - Define deletion boundaries and test COL4A5 rather than attributing hearing loss categorically to COL4A6.
  evidence:
  - reference: PMID:20301386
    reference_title: "Alport Syndrome."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Alport syndrome is characterized by kidney manifestations, sensorineural
      hearing loss (SNHL), and ocular manifestations.
    explanation: >-
      GeneReviews defines the renal-auditory-ocular combination distinguishing
      Alport syndrome from isolated hearing loss.
  - reference: PMID:20301386
    reference_title: "Alport Syndrome."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      in those with deletions of COL4A5 extending into intron 2 of COL4A6,
      surgical intervention for symptomatic leiomyomas as needed
    explanation: >-
      The contiguous-deletion management statement anchors the distinct
      COL4A5-COL4A6 Alport/leiomyomatosis phenotype.
- name: OTOF-related and other auditory neuropathy spectrum disorders
  description: >-
    OTOF and other genetic or acquired ANSD causes share the OAE/ABR
    dissociation with AIFM1. Age at onset, inheritance, neurologic findings,
    MRI, and molecular testing distinguish them; an ANSD physiologic pattern is
    not specific for DFNX5.
  distinguishing_features:
  - Biallelic OTOF disease usually presents in infancy and follows autosomal recessive inheritance.
  - AIFM1 was confined to the non-infant group in one large cohort and may later add sensory neuropathy or cochlear nerve hypoplasia.
  - Perinatal, toxic, infectious, and immune causes require clinical exclusion when genetic testing is uninformative.
  evidence:
  - reference: PMID:38456936
    reference_title: "Clinical and genetic architecture of a large cohort with auditory neuropathy."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Most of the OTOF gene (96.6%, 28/29) could only be identified in the
      infant group, while the AIFM1 gene could only be identified in the
      non-infant group
    explanation: >-
      The cohort supports age-at-onset as a useful, nonabsolute discriminator
      between OTOF- and AIFM1-associated auditory neuropathy.
- name: Other inner-ear malformations versus POU3F4 incomplete partition type III
  description: >-
    Other incomplete-partition patterns, enlarged vestibular aqueduct, cochlear
    hypoplasia, and cochlear-nerve deficiency can all accompany hearing loss.
    The specific temporal-bone CT pattern and POU3F4 testing distinguish IP-III.
  distinguishing_features:
  - IP-III retains the interscalar septa but lacks the modiolus and has a widened lateral internal auditory canal directly communicating with the cochlea.
  - A perilymphatic gusher risk and POU3F4 variant or upstream deletion further favor IP-III.
  - MRI complements CT when cochlear nerve deficiency rather than a bony partition anomaly is suspected.
  evidence:
  - reference: PMID:30065609
    reference_title: "X-Linked Sensorineural Hearing Loss: A Literature Review."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Cochlear malformation was shown to consist of a relatively normal outer
      coat shape, absence of a cochlear modiolus, and a direct inter
      communication between the IAC and cochlear inner cavity.
    explanation: >-
      The characteristic CT anatomy distinguishes POU3F4/IP-III from other
      inner-ear malformations.
treatments:
- name: Hearing-aid amplification
  description: >-
    Hearing aids are a primary treatment option for childhood-onset bilateral
    sensorineural hearing loss. The available abstract-level evidence supports
    this general treatment statement.
  therapeutic_modality: DEVICE
  treatment_term:
    preferred_term: hearing-aid amplification
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:36633841
    reference_title: "Association of Genetic Diagnoses for Childhood-Onset Hearing Loss With Cochlear Implant Outcomes."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Primary treatments are hearing aids and cochlear implants.
    explanation: >-
      The PubMed abstract supports hearing aids as a general primary treatment
      for childhood-onset bilateral sensorineural hearing loss; it does not
      support subtype-specific or genotype-directed claims.
- name: Cochlear implantation for POU3F4/IP-III anatomy
  description: >-
    Cochlear implantation is a major intervention for severe POU3F4-related
    IP-III hearing loss, but the malformation increases surgical complexity and
    requires careful preoperative assessment and postoperative verification.
  therapeutic_modality: SURGERY
  treatment_term:
    preferred_term: cochlear implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
  target_phenotypes:
  - preferred_term: Sensorineural hearing impairment
    term:
      id: HP:0000407
      label: Sensorineural hearing impairment
  evidence:
  - reference: PMID:38498189
    reference_title: "Research progress on incomplete partition type 3 inner ear malformation."
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      cochlear implantation currently serving as the predominant therapeutic
      approach.
    explanation: >-
      The IP-III review supports cochlear implantation as the predominant
      therapeutic approach for this malformation-associated form of X-linked
      deafness.
- name: Genetic Counseling
  description: >-
    Genetic counseling is important for recurrence-risk counseling, sex-linked
    inheritance counseling, and genotype-informed management decisions in DFNX
    families.
  treatment_term:
    preferred_term: Genetic Counseling
    term:
      id: NCIT:C15240
      label: Genetic Counseling
  evidence:
  - reference: PMID:39272213
    reference_title: "Genomic and phenotypic landscapes of X-linked hereditary hearing loss in the Chinese population."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Analysis of the genotype-phenotype relationship is valuable for X-linked
      HL precise diagnostics and genetic counseling.
    explanation: >-
      The cohort conclusion directly supports genetic counseling as a
      management implication of genotype-phenotype analysis.
discussions:
- discussion_id: mismatch_col4a6_knockout_human_hearing
  prompt: >-
    Why does complete Col4a6 loss in mice leave click-ABR thresholds and
    cochlear morphology normal when human COL4A6 variants have been reported
    with DFNX6, and do allele-specific effects rather than simple loss of
    expression explain the difference?
  kind: HUMAN_MODEL_MISMATCH
  status: OPEN
  attaches_to:
  - pathophysiology#Candidate COL4A6-associated cochlear basement-membrane involvement
  - phenotypes#Sensorineural hearing impairment
  rationale: >-
    The knockout is a narrow refutation of simple loss of Col4a6 expression
    being sufficient to produce severe hearing loss or cochlear malformation in
    this mouse model. It does not test the reported human missense or splice
    alleles and therefore does not broadly refute human COL4A6 causality. The
    mismatch matters because a null model could miss dominant-negative,
    aberrant-heterotrimer, allele-specific splicing, species-specific
    basement-membrane, or frequency-specific auditory effects.
  proposed_experiments:
  - experiment_id: exp_col4a6_allele_matched_mouse_comparison
    name: Allele-matched Col4a6 knock-in and knockout comparison
    description: >-
      Compare mice carrying orthologous versions of the reported human
      p.Gly591Ser missense and c.951+1G>T splice variants with the existing null
      allele and wild-type controls. Measure frequency-specific ABR and DPOAE
      thresholds, cochlear microanatomy, collagen alpha5-alpha6-alpha5(IV)
      assembly, and basement-membrane ultrastructure across development.
    decision_criterion: >-
      An auditory or cochlear phenotype confined to a reported-variant knock-in,
      with abnormal collagen heterotrimer assembly, would support an allele-specific
      mechanism missed by the null model. Normal auditory, structural, and
      collagen-assembly readouts in both knock-in models would weaken the reported
      variants' proposed cochlear mechanism.
  - experiment_id: exp_col4a6_isogenic_human_inner_ear_models
    name: Isogenic human inner-ear model of COL4A6 variant and null alleles
    description: >-
      Engineer the two reported COL4A6 variants and a matched null allele in
      human iPSC-derived inner-ear or cochlear basement-membrane models, then
      compare transcript splicing, alpha6(IV) protein incorporation, heterotrimer
      assembly, extracellular-matrix organization, and rescue after correction
      of each allele.
    decision_criterion: >-
      Variant-specific abnormalities that are rescued by correction but are absent
      from the null line would bridge the mouse-human mismatch and support a non-null
      mechanism. Absence of reproducible variant-specific abnormalities after
      isogenic correction and rescue would weaken the proposed human cochlear
      mechanism.
  evidence:
  - reference: PMID:33848312
    reference_title: "Lack of collagen α6(IV) chain in mice does not cause severe-to-profound hearing loss or cochlear malformation, a distinct phenotype from nonsyndromic hearing loss with COL4A6 missense mutation."
    supports: REFUTE
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Hence, loss of Col4a6 gene expression in mice showed normal click ABR
      thresholds and normal cochlear formation, which differs from humans with
      the COL4A6 missense mutation c.1771G>A, p.Gly591Ser.
    explanation: >-
      This abstract-level negative result narrowly refutes simple loss of
      expression as sufficient in the mouse model. It does not test the human
      alleles or refute broad human gene-disease causality.
datasets: []
📚

References & Deep Research

References

2
PMID:20301607
Genetic Hearing Loss Overview.
No top-level findings curated for this source.
PMID:20301738
Phosphoribosylpyrophosphate Synthetase Deficiency.
No top-level findings curated for this source.

Deep Research

1
Falcon ▸
1. Disease Information
Edison Scientific Literature 26 citations 2026-05-08T12:36:34.954187

1. Disease Information

1.1 Definition and overview

X-linked deafness (DFNX) refers to hereditary hearing loss caused by pathogenic variants on the X chromosome and includes both syndromic and nonsyndromic entities; “DFNX” is typically used for X-linked nonsyndromic hearing loss in the hereditary hearing-loss locus nomenclature (bernardinelli2023clinicalandmolecular pages 1-2, jiang2023advancesingene pages 1-2). Clinical expression is often sex-influenced: hemizygous males are most severely affected, while heterozygous females may show variable hearing loss due to X-chromosome inactivation effects (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 4-5).

1.2 Key identifiers (gene/locus-level identifiers available in evidence)

A 2024 Orphanet Journal of Rare Diseases cohort analysis explicitly lists major DFNX gene–locus mappings (including MIM numbers) (feng2024genomicandphenotypic pages 1-2): - PRPS1: DFNX1 (MIM#304500) (feng2024genomicandphenotypic pages 1-2) - POU3F4: DFNX2 / DFN3 (MIM#304400); gene OMIM *300039 (bernardinelli2023clinicalandmolecular pages 1-2, bernardinelli2023clinicalandmolecular pages 5-7) - SMPX: DFNX4 (MIM#300066) (feng2024genomicandphenotypic pages 1-2) - AIFM1: DFNX5 (MIM#300614) (feng2024genomicandphenotypic pages 1-2) - COL4A6: DFNX6 (MIM#303630) (feng2024genomicandphenotypic pages 1-2)

1.3 Synonyms / alternative names

  • “X-linked deafness (DFNX)” (broad category including syndromic and nonsyndromic) (bernardinelli2023clinicalandmolecular pages 1-2)
  • “X-linked nonsyndromic hearing loss (DFNX)” (feng2024genomicandphenotypic pages 1-2)
  • POU3F4-related X-linked deafness type 3: DFN3 (also referenced as DFNX2) (bernardinelli2023clinicalandmolecular pages 5-7, bernardinelli2023clinicalandmolecular pages 20-21)

1.4 Evidence source type

The information summarized here is derived from aggregated disease-level resources (peer-reviewed reviews) and cohort-based clinical genetics studies (large case series) rather than EHR-only summaries (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 1-2).

2. Etiology

2.1 Disease causal factors

Primary cause: germline pathogenic variation in X-chromosome genes important for auditory development and/or cochlear cellular function (feng2024genomicandphenotypic pages 1-2, bernardinelli2023clinicalandmolecular pages 1-2).

2.2 Risk factors

  • Genetic risk factor: carrying pathogenic variants in DFNX genes (e.g., POU3F4, PRPS1, SMPX, AIFM1, COL4A6) (feng2024genomicandphenotypic pages 1-2).
  • Sex as a modifier: males typically more severely affected due to hemizygosity; females may exhibit variable expressivity due to skewed X-inactivation (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 4-5).

2.3 Protective factors / gene–environment interaction

No DFNX-specific protective factors or gene–environment interaction data were identified in the retrieved evidence.

3. Phenotypes (HPO-aligned)

3.1 Core phenotype domain

  • Hearing impairment / sensorineural hearing loss (HP:0000365 / HP:0000407) is the defining phenotype across DFNX genes (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5).

3.2 Age of onset and severity (recent cohort statistics)

In a 2024 Chinese cohort of 3646 unrelated patients with hearing loss (HL), X-linked diagnoses were ~1.14% of genetically solved cases (22/1922) and clinical onset among X-linked HL cases was congenital or childhood in all cases; severity in evaluated probands with X-linked variants was predominantly severe–profound (25/29) (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5).

3.3 Gene-associated phenotype highlights

POU3F4 (DFNX2/DFN3)

  • Often severe to profound hearing loss with pathognomonic inner-ear malformation: incomplete partition type III (IP-III) (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 4-5).
  • Imaging features reported include absent/defective modiolus and interscalar septa, dilated internal auditory canal (IAC), and deficient bony separation between cochlea and IAC (feng2024genomicandphenotypic pages 4-5, feng2024genomicandphenotypic pages 6-7). The radiologic comparison (normal vs IP-III) is shown in the retrieved figure (bernardinelli2023clinicalandmolecular media 04c7488e).
  • Suggested HPO terms: Abnormality of the inner ear morphology (HP:0000364), Cochlear malformation (HP:0008551), Perilymphatic gusher (HP term not universally standardized; clinical descriptor supported by evidence) (bernardinelli2023clinicalandmolecular pages 1-2, jung2023geneticcharacteristicsand pages 1-2).

PRPS1 (DFNX1)

  • Reported as a phenotypic spectrum ranging from isolated HL to more severe syndromes; within the provided cohort summary, male cases can show progressive hearing loss with onset ranging from congenital through teenage years and severity from moderate to profound (feng2024genomicandphenotypic pages 4-5).
  • Suggested HPO terms: Progressive sensorineural hearing impairment (HP:0000408) (feng2024genomicandphenotypic pages 4-5).

SMPX (DFNX4)

  • Associated with progressive nonsyndromic hearing loss; truncating variants are associated with typical audiological profiles in childhood (before/after age 10), whereas nontruncating changes were noted as linking more often to distal myopathy phenotypes (not nonsyndromic HL) (feng2024genomicandphenotypic pages 1-2).
  • Female carriers may have variable, later-onset hearing loss (often 4th–5th decade), from unilateral/normal to mild–moderate symmetric/asymmetric loss (feng2024genomicandphenotypic pages 6-7).
  • Suggested HPO terms: Progressive hearing impairment (HP:0000408), Asymmetric sensorineural hearing impairment (HP:0008619).

AIFM1 (DFNX5)

  • Can present as auditory neuropathy with postsynaptic lesion and progressive auditory dyssynchrony; cochlear nerve hypoplasia may occur (feng2024genomicandphenotypic pages 10-12).
  • Suggested HPO terms: Auditory neuropathy (HP:0030781), Cochlear nerve hypoplasia (HP:0030795).

COL4A6 (DFNX6)

  • In the 2024 cohort, no phenotypic differences were identified among POU3F4 or COL4A6 carriers, but cochlear malformation (e.g., cochlear hypoplasia) was described for a COL4A6 variant example (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 2-4).

3.4 Quality-of-life impact

Direct QoL instrument data (EQ-5D/SF-36/PROMIS) specific to DFNX were not identified in the retrieved evidence; however, severe–profound congenital/childhood hearing loss implies major communication and developmental impacts, motivating early diagnosis and intervention (feng2024genomicandphenotypic pages 4-5).

4. Genetic / Molecular Information

4.1 Causal genes

A recent large cohort review of X-linked hereditary HL highlights the principal DFNX genes: PRPS1, POU3F4, SMPX, AIFM1, COL4A6 (feng2024genomicandphenotypic pages 1-2). POU3F4 is emphasized as the most common gene for X-linked nonsyndromic HL in reviews and cohorts (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 1-2).

4.2 Variant types and functional consequences (by gene)

POU3F4 (DFNX2/DFN3)

POU3F4 variants include missense, nonsense, frameshift (single coding exon), as well as larger deletions/insertions/inversions and upstream regulatory deletions affecting expression (bernardinelli2023clinicalandmolecular pages 5-7). The 2024 cohort further reports CNVs including whole-gene deletion (~165 kb) and notes clustering of pathogenic changes in the POU-specific domain and homeodomain with frequent truncation outcomes (feng2024genomicandphenotypic pages 2-4, feng2024genomicandphenotypic pages 6-7). Functionally characterized variants can show abnormal subcellular localization and impaired nuclear trafficking/transcriptional activity (bernardinelli2023clinicalandmolecular pages 5-7).

PRPS1 (DFNX1) and AIFM1 (DFNX5)

In the 2024 cohort analysis, causative variants in PRPS1 and AIFM1 were mainly missense, and phenotypic variability was proposed to correlate with residue-level structural/function effects (feng2024genomicandphenotypic pages 1-2).

SMPX (DFNX4)

SMPX DFNX4 is described as X-linked dominant NSHL with a reported set of 15 causative variants, mostly truncating and splice-site variants with a minority nontruncating/missense variants (feng2024genomicandphenotypic pages 6-7). A genotype–phenotype distinction was noted in which truncating variants were associated with DFNX4 hearing-loss profiles, while nontruncating variants were linked to distal myopathy phenotypes (feng2024genomicandphenotypic pages 1-2).

4.3 Modifier genes / epigenetics

No specific modifier-gene findings or epigenetic mechanisms were identified in the retrieved DFNX-focused evidence; sex-related variability due to X-inactivation is an important mechanism for phenotypic differences in females (feng2024genomicandphenotypic pages 4-5).

5. Environmental Information

DFNX is primarily genetic. No DFNX-specific environmental contributors were identified in the retrieved evidence.

6. Mechanism / Pathophysiology (with ontology suggestions)

6.1 POU3F4: developmental malformation mechanism leading to IP-III

POU3F4 encodes a transcription factor with a major role in middle/inner ear development (bernardinelli2023clinicalandmolecular pages 1-2). The characteristic DFNX2/DFN3 clinical chain supported by the evidence is: 1) POU3F4 pathogenic variant → 2) altered transcription factor function/expression (including mislocalization for some variants) → 3) disrupted ear development and characteristic IP-III cochlear/IAC anatomy → 4) severe congenital/early hearing loss and surgery-specific risks such as CSF/perilymphatic “gusher” due to abnormal cochlea–IAC communication (bernardinelli2023clinicalandmolecular pages 5-7, feng2024genomicandphenotypic pages 4-5, jung2023geneticcharacteristicsand pages 1-2).

Ontology suggestions - UBERON: cochlea (UBERON:0001766), internal auditory canal (UBERON:0001675), stria vascularis (UBERON:0001845). - CL (cell types): otic mesenchyme cell (not always present as a distinct CL label in curated ontologies; mechanistic role supported by review and IP-III literature), cochlear supporting cell, spiral ganglion neuron. - GO biological process: inner ear development; regulation of transcription.

6.2 SMPX: hair-cell/kinocilium and mechanotransduction phenotype (model organism evidence; 2024)

A 2024 Scientific Reports study provides in vivo functional evidence that smpx is required for mechanosensory hair-cell development/function in zebrafish lateral line neuromasts, with Smpx localized to hair-cell cytoplasm and kinocilium and loss-of-function producing abnormal kinocilia and reduced mechanotransduction (e.g., reduced FM dye uptake) (diana2024differentiationandfunctioning pages 1-2, diana2024differentiationandfunctioning pages 2-3). This supports a causal chain: 1) SMPX loss-of-function → 2) impaired hair-cell structural integrity (including kinocilium changes) → 3) reduced mechanotransduction → 4) progressive hearing loss in humans (DFNX4) (diana2024differentiationandfunctioning pages 1-2).

Direct abstract-supported statement (model evidence): the paper describes SMPX as “highly expressed in the inner ear hair cells (HCs)” and notes that SMPX mutations have been associated with “X-chromosomal progressive non syndromic hearing loss in humans” (diana2024differentiationandfunctioning pages 1-2).

Ontology suggestions - CL: sensory hair cell (CL:0000601). - GO: sensory perception of sound; mechanotransduction; cilium organization. - UBERON: organ of Corti (UBERON:0001894).

6.3 AIFM1: auditory neuropathy phenotype

The 2024 DFNX cohort synthesis notes that AIFM1-related auditory neuropathy involves postsynaptic lesions and progressive dyssynchrony; cochlear nerve hypoplasia may occur (feng2024genomicandphenotypic pages 10-12). Mechanistically, this points to neural/synaptic dysfunction downstream of cochlear mechanics.

7. Anatomical Structures Affected

7.1 Primary structures

  • Inner ear/cochlea (UBERON:0001766) across DFNX conditions (feng2024genomicandphenotypic pages 1-2).
  • IAC–cochlea interface and modiolus in POU3F4/IP-III (feng2024genomicandphenotypic pages 4-5, bernardinelli2023clinicalandmolecular media 04c7488e).

7.2 Cell types (evidence-supported)

  • Sensory hair cells (especially for SMPX) (diana2024differentiationandfunctioning pages 1-2).

7.3 Subcellular compartments

SMPX localization includes the kinocilium and cytoplasm in zebrafish hair cells, supporting involvement of ciliary and cytoskeletal structures (diana2024differentiationandfunctioning pages 2-3).

8. Temporal Development

8.1 Onset

In a large 2024 molecular epidemiology study, X-linked hereditary HL cases were congenital or began in childhood (feng2024genomicandphenotypic pages 1-2). For SMPX, female carrier onset may occur later (4th–5th decade) (feng2024genomicandphenotypic pages 6-7).

8.2 Progression

  • Progressive course is highlighted for PRPS1 male cases and SMPX DFNX4 (feng2024genomicandphenotypic pages 4-5, feng2024genomicandphenotypic pages 6-7).

9. Inheritance and Population

9.1 Inheritance patterns

  • DFNX conditions are X-linked; DFNX phenotypes show sex-related differences due to X-inactivation (feng2024genomicandphenotypic pages 4-5).
  • SMPX (DFNX4) is described as X-linked dominant nonsyndromic hearing loss (feng2024genomicandphenotypic pages 6-7).

9.2 Epidemiology (quantitative data from recent studies)

  • A 2023 review estimates DFNX accounts for up to ~2% of hereditary hearing loss and that POU3F4 accounts for ~50% of X-linked nonsyndromic hearing loss (bernardinelli2023clinicalandmolecular pages 1-2).
  • In a 2024 Chinese cohort, the aggregate contribution of X-chromosome genes to genetically solved HL was ~1.14% (22/1922), with POU3F4 representing ~59% (13/22) of those X-linked diagnosed cases (feng2024genomicandphenotypic pages 1-2).

Population variant frequencies (e.g., gnomAD allele frequencies), founder effects, and carrier frequencies were not available in the retrieved evidence set.

10. Diagnostics

10.1 Clinical tests and phenotyping

A recent large cohort used: - Audiologic assessment including PTA, ABR, DPOAE, and clinical severity grading (feng2024genomicandphenotypic pages 2-4). - Temporal bone imaging (HRCT / MRI) to detect malformations such as IP-III (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5).

10.2 Genetic testing strategies (real-world implementation)

In the 2024 Chinese study, genetic diagnosis relied on a combination of a 227-gene panel (majority of cases) and whole-exome sequencing, with third-generation sequencing (TGS) used when prior NGS approaches did not yield a diagnosis; the overall molecular diagnostic yield across 3646 probands was 52.72% (1922/3646) (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 2-4).

10.3 Differential diagnosis considerations (DFNX vs syndromic X-linked disorders)

The DFNX framework explicitly distinguishes X-linked nonsyndromic HL genes from syndromic X-linked conditions with HL (e.g., Norrie, Alport) (feng2024genomicandphenotypic pages 1-2).

10.4 Screening

The evidence emphasizes early genetic diagnosis and monitoring (especially where progression is expected) but did not provide specific newborn screening or carrier screening program metrics.

11. Outcome / Prognosis

11.1 Hearing outcomes and intervention response

  • Cochlear implantation in IP-III: In a 2023 cohort of 11 IP-III patients, 9/11 had POU3F4 pathogenic variants, all surgeries had CSF gushers, and postoperative auditory performance (CAP scores) improved significantly (jung2023geneticcharacteristicsand pages 1-2).
  • CI outcomes in IP-III are described as variable across reports, and long-term device/linguistic performance may diverge from typical pediatric CI populations (xu2024researchprogresson pages 2-4).

No DFNX-specific mortality or life-expectancy impacts were identified.

12. Treatment

12.1 Standard-of-care treatments and implementations

  • Hearing aids and cochlear implantation (CI) are the principal current interventions in DFNX populations, selected based on severity and benefit (feng2024genomicandphenotypic pages 10-12, feng2024genomicandphenotypic pages 4-5).

12.2 DFNX2/DFN3 (POU3F4) surgical considerations (real-world constraints)

POU3F4/IP-III malformation creates high-risk anatomy (direct cochlea–IAC communication), leading to: - Perilymphatic/CSF gusher risk during surgery (highlighted as universal in the 2023 IP-III CI cohort) (jung2023geneticcharacteristicsand pages 1-2). - Electrode misplacement into the IAC risk; recommendations include specialized electrodes (e.g., “cork” stopper / rings), intra-operative CT confirmation, and other intraoperative sealing/packing strategies (xu2024researchprogresson pages 2-4, feng2024genomicandphenotypic pages 10-12).

12.3 Advanced therapeutics and experimental approaches (2023–2024 landscape)

Gene therapy: state of the field and applicability to DFNX

A 2023 Molecular Therapy review summarizes that inner ear gene therapy strategies typically include gene replacement, gene suppression, and gene editing, and emphasizes the practical advantage of local inner-ear delivery due to its confined fluid-filled anatomy (jiang2023advancesingene pages 1-2, jiang2023advancesingene pages 13-14). It also states that “DFNA, DFNB, and DFNX” denote autosomal dominant, autosomal recessive, and X-linked deafness classifications, respectively (jiang2023advancesingene pages 1-2).

Clinical translation in 2023–2024 (trial reality): the retrieved clinical-trial landscape is currently dominated by autosomal recessive targets (notably OTOF/DFNB9) rather than DFNX genes. Examples include: - DB-OTO (AAV-based) in children/infants with OTOF-related hearing loss (ClinicalTrials.gov NCT05788536, recruiting) (clinical trials search results). - Additional OTOF programs (e.g., NCT06722170) and an RNA base-editing study (NCT06025032, withdrawn) (clinical trials search results).

No DFNX gene-targeted interventional gene therapy trial was identified in the retrieved ClinicalTrials.gov results.

12.4 MAXO term suggestions

  • Hearing aid fitting (MAXO term not retrieved here; concept: hearing aid therapy) (feng2024genomicandphenotypic pages 4-5)
  • Cochlear implantation (MAXO concept) (jung2023geneticcharacteristicsand pages 1-2)
  • Genetic counseling (MAXO concept) (feng2024genomicandphenotypic pages 1-2)

13. Prevention

No DFNX-specific primary prevention is established (genetic etiology). Secondary/tertiary prevention is largely through early identification, timely hearing rehabilitation, and genotype-informed surgical planning (feng2024genomicandphenotypic pages 4-5, jung2023geneticcharacteristicsand pages 1-2).

14. Other species / natural disease

No naturally occurring DFNX-analog disease in companion animals was identified in the retrieved evidence.

15. Model organisms

  • Zebrafish smpx loss-of-function provides a 2024 in vivo mechanistic model showing impaired mechanosensory hair-cell development/function and reduced mechanotransduction, relevant to SMPX DFNX4 pathogenesis (diana2024differentiationandfunctioning pages 1-2, diana2024differentiationandfunctioning pages 2-3).

Expert synthesis (2023–2024 authoritative interpretation)

1) POU3F4 is the dominant DFNX gene in practice: reviews estimate POU3F4 accounts for ~50% of X-linked nonsyndromic HL and DFNX overall contributes up to ~2% of hereditary HL; a large 2024 cohort similarly found POU3F4 comprised ~59% of solved X-linked cases (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 1-2). This convergence supports prioritizing POU3F4 in DFNX diagnostic algorithms and pre-surgical planning. 2) Genotype-informed otologic surgery is a real-world necessity: IP-III anatomy produces predictable intraoperative risks (CSF gusher, electrode misplacement). Cohort-level surgical evidence shows universal CSF gusher in IP-III CI and significant functional improvement post-CI, supporting CI as beneficial but requiring specialized technique and counseling (jung2023geneticcharacteristicsand pages 1-2, xu2024researchprogresson pages 2-4). 3) Therapeutic frontier is moving, but DFNX-specific gene therapy is not yet clinical: 2023–2024 gene therapy progress is substantial in hereditary HL broadly (vectors, routes, editing strategies), but current registered interventional trials in retrieved evidence largely target DFNB9/OTOF rather than DFNX (jiang2023advancesingene pages 1-2).

Summary tables and key visuals

The following table consolidates DFNX gene–phenotype–variant–management mappings extracted from the evidence.

Gene DFNX subtype / OMIM MIM number (as reported in evidence) Protein/function (brief) Typical phenotype (onset, severity, progression, imaging) Common variant types (missense/truncating/CNV/regulatory) Notes on management (CI, surgical risk) Key recent/authoritative sources with year, DOI/URL, and PMID if present in text
PRPS1 DFNX1; MIM#304500 (feng2024genomicandphenotypic pages 1-2) Phosphoribosyl pyrophosphate synthetase 1; enzyme in nucleotide/purine biosynthesis spectrum disorders (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5) Congenital to childhood onset in cohort; male patients can show progressive hearing loss ranging from moderate to profound; may present as isolated HL or part of broader PRPS1 spectrum (feng2024genomicandphenotypic pages 4-5) Predominantly missense; one duplication variant noted (c.937_940dup) (feng2024genomicandphenotypic pages 4-5) Hearing aids may be insufficient in some cases; cochlear implantation (CI) improved hearing and communication in cohort when HA benefit was limited, but gene-specific quantitative CI data for PRPS1 were not provided (feng2024genomicandphenotypic pages 4-5, feng2024genomicandphenotypic pages 2-4) Feng et al., 2024, Orphanet J Rare Dis; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: — (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 4-5)
POU3F4 DFNX2 / DFN3; OMIM #304400; gene OMIM *300039 (bernardinelli2023clinicalandmolecular pages 1-2, bernardinelli2023clinicalandmolecular pages 5-7, feng2024genomicandphenotypic pages 6-7) POU-family transcription factor critical for middle/inner ear development (otic mesenchyme/cochlear development) (bernardinelli2023clinicalandmolecular pages 1-2, xu2024researchprogresson pages 1-2) Usually congenital or childhood-onset, often severe to profound HL; hallmark imaging is incomplete partition type III (IP-III) with absent modiolus/interscalar septa, dilated IAC, abnormal communication between cochlea and IAC; can have mixed or sensorineural HL (bernardinelli2023clinicalandmolecular pages 1-2, feng2024genomicandphenotypic pages 4-5, feng2024genomicandphenotypic pages 6-7, xu2024researchprogresson pages 2-4) Missense, nonsense, frameshift, indels, structural variants/CNVs, whole-gene deletions, upstream regulatory deletions/insertions/inversions (bernardinelli2023clinicalandmolecular pages 5-7, feng2024genomicandphenotypic pages 2-4, jung2023geneticcharacteristicsand pages 1-2) Most important real-world management issue in DFNX: CI is standard but technically difficult in IP-III. Risks include CSF/perilymphatic gusher and electrode misplacement into the IAC; pre-op CT/MRI, intra-op imaging, sealing cochleostomy, and shorter/straight or special stopper/ring electrodes are recommended. In one 2023 series of 11 IP-III patients, all CI surgeries had CSF gushers and CAP scores improved postoperatively (jung2023geneticcharacteristicsand pages 1-2, xu2024researchprogresson pages 2-4, feng2024genomicandphenotypic pages 10-12) Bernardinelli et al., 2023, Biomedicines; DOI: 10.3390/biomedicines11061695; URL: https://doi.org/10.3390/biomedicines11061695; PMID: —. Feng et al., 2024; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: —. Jung et al., 2023; DOI: 10.21053/ceo.2023.00864; URL: https://doi.org/10.21053/ceo.2023.00864; PMID: —. Xu et al., 2024; DOI: 10.1007/s00405-024-08555-7; URL: https://doi.org/10.1007/s00405-024-08555-7; PMID: — (bernardinelli2023clinicalandmolecular pages 1-2, bernardinelli2023clinicalandmolecular pages 5-7, jung2023geneticcharacteristicsand pages 1-2, xu2024researchprogresson pages 2-4)
SMPX DFNX4; MIM#300066 (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 6-7) Small muscle protein, X-linked; cytoskeleton-associated protein highly expressed in inner-ear hair cells, linked to hair-cell differentiation/maintenance and mechanotransduction (diana2024differentiationandfunctioning pages 1-2, diana2024differentiationandfunctioning pages 2-3) Typically progressive NSHL; truncating variants associated with characteristic audiological profiles before and after age 10; female carriers may show variable expressivity, often later onset (4th–5th decade), mild–moderate, symmetric or asymmetric HL; no signature malformation emphasized (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 6-7) Reported pathogenic spectrum includes truncating variants (10/15), splice-site variants (3/15), and a small number of nontruncating/missense variants; truncating variants linked to DFNX4, whereas nontruncating variants have been associated with distal myopathy (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 6-7) Standard hearing rehabilitation applies; no DFNX4-specific CI risk profile reported in the provided evidence. Mechanistic animal work supports future targetability by molecular therapies, but no DFNX4 clinical gene therapy trial was identified here (feng2024genomicandphenotypic pages 1-2, diana2024differentiationandfunctioning pages 1-2) Feng et al., 2024; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: —. Diana et al., 2024, Sci Rep; DOI: 10.1038/s41598-024-58138-z; URL: https://doi.org/10.1038/s41598-024-58138-z; PMID: — (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 6-7, diana2024differentiationandfunctioning pages 1-2)
AIFM1 DFNX5; MIM#300614 (feng2024genomicandphenotypic pages 1-2) Apoptosis-inducing factor, mitochondria-associated; evidence emphasizes structural/functional residue effects and auditory-neuropathy phenotype (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 10-12) Congenital or childhood-onset X-linked HL in cohort; causative variants mainly missense; associated with auditory neuropathy, postsynaptic lesions, progressive auditory dyssynchrony, and sometimes cochlear nerve hypoplasia (CNH) (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 10-12) Predominantly missense (feng2024genomicandphenotypic pages 1-2) CI may have limited success in AIFM1-related auditory neuropathy compared with some other genetic etiologies; genotype can help guide expectations and treatment choice (feng2024genomicandphenotypic pages 10-12) Feng et al., 2024; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: — (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 10-12)
COL4A6 DFNX6; MIM#303630 (feng2024genomicandphenotypic pages 1-2) Type IV collagen alpha-6 chain; extracellular matrix/basement membrane component (function not elaborated in detail in provided evidence) (feng2024genomicandphenotypic pages 1-2) Congenital or childhood-onset HL in cohort; no clear phenotypic differences highlighted among carriers in the 2024 Chinese series; can be associated with cochlear malformation, with one reported example of cochlear hypoplasia and profound SNHL (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 2-4) Specific recurrent class not summarized in detail in provided evidence; sequence variants reported, including missense example c.1456G>A (feng2024genomicandphenotypic pages 2-4) CI can be successful in some malformation-associated DFNX cases; the evidence specifically contrasts better potential CI outcomes in some structural-gene cases with poorer results in AIFM1 auditory neuropathy, but COL4A6-specific outcome statistics were not provided (feng2024genomicandphenotypic pages 10-12, feng2024genomicandphenotypic pages 2-4) Feng et al., 2024; DOI: 10.1186/s13023-024-03338-z; URL: https://doi.org/10.1186/s13023-024-03338-z; PMID: — (feng2024genomicandphenotypic pages 1-2, feng2024genomicandphenotypic pages 2-4)

Table: This table summarizes the principal genes and loci implicated in X-linked nonsyndromic hearing loss, with phenotype, variant spectrum, and management implications drawn only from the provided evidence. It is useful for rapid comparison of DFNX subtypes and for linking genotype to imaging and cochlear implant considerations.

A radiologic comparison figure of normal cochlea vs IP-III and a POU3F4 variant summary table were retrieved from a 2023 review; these support the hallmark IP-III malformation and the breadth of reported variant types (bernardinelli2023clinicalandmolecular media 04c7488e, bernardinelli2023clinicalandmolecular media 46a2f715).

Notes on evidence gaps

  • PMIDs were not present in the retrieved text excerpts for the key sources; DOIs and journal publication months/years are provided where available.
  • MONDO/Orphanet/ICD/MeSH IDs for the umbrella “X-linked nonsyndromic hearing loss” term were not retrieved in this tool run.
  • Population allele frequencies (gnomAD) and founder variants were not identified in the retrieved evidence.

References

  1. (bernardinelli2023clinicalandmolecular pages 1-2): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.

  2. (feng2024genomicandphenotypic pages 1-2): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  3. (jiang2023advancesingene pages 1-2): Luoying Jiang, Daqi Wang, Yingzi He, and Yilai Shu. Advances in gene therapy hold promise for treating hereditary hearing loss. Molecular Therapy, 31:934-950, Apr 2023. URL: https://doi.org/10.1016/j.ymthe.2023.02.001, doi:10.1016/j.ymthe.2023.02.001. This article has 127 citations and is from a highest quality peer-reviewed journal.

  4. (feng2024genomicandphenotypic pages 4-5): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  5. (bernardinelli2023clinicalandmolecular pages 5-7): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.

  6. (bernardinelli2023clinicalandmolecular pages 20-21): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.

  7. (feng2024genomicandphenotypic pages 6-7): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  8. (bernardinelli2023clinicalandmolecular media 04c7488e): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.

  9. (jung2023geneticcharacteristicsand pages 1-2): Jinsei Jung, Se A Lee, Un-Kyung Kim, In Seok Moon, Heon Yung Gee, and Jae Young Choi. Genetic characteristics and audiological performance after cochlear implantation in patients with incomplete partition type iii. Clinical and Experimental Otorhinolaryngology, 16:403-406, Nov 2023. URL: https://doi.org/10.21053/ceo.2023.00864, doi:10.21053/ceo.2023.00864. This article has 1 citations and is from a peer-reviewed journal.

  10. (feng2024genomicandphenotypic pages 10-12): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  11. (feng2024genomicandphenotypic pages 2-4): Haifeng Feng, Shasha Huang, Ying Ma, Jinyuan Yang, Yijin Chen, Guojian Wang, Mingyu Han, Dongyang Kang, Xin Zhang, Pu Dai, and Yongyi Yuan. Genomic and phenotypic landscapes of x-linked hereditary hearing loss in the chinese population. Orphanet Journal of Rare Diseases, Sep 2024. URL: https://doi.org/10.1186/s13023-024-03338-z, doi:10.1186/s13023-024-03338-z. This article has 6 citations and is from a peer-reviewed journal.

  12. (diana2024differentiationandfunctioning pages 1-2): Alberto Diana, Anna Ghilardi, and Luca Del Giacco. Differentiation and functioning of the lateral line organ in zebrafish require smpx activity. Scientific Reports, Apr 2024. URL: https://doi.org/10.1038/s41598-024-58138-z, doi:10.1038/s41598-024-58138-z. This article has 1 citations and is from a peer-reviewed journal.

  13. (diana2024differentiationandfunctioning pages 2-3): Alberto Diana, Anna Ghilardi, and Luca Del Giacco. Differentiation and functioning of the lateral line organ in zebrafish require smpx activity. Scientific Reports, Apr 2024. URL: https://doi.org/10.1038/s41598-024-58138-z, doi:10.1038/s41598-024-58138-z. This article has 1 citations and is from a peer-reviewed journal.

  14. (xu2024researchprogresson pages 2-4): Kaifan Xu, Yun Xiao, Jianfen Luo, Xiuhua Chao, Ruijie Wang, Zhaoming Fan, Haibo Wang, and Lei Xu. Research progress on incomplete partition type 3 inner ear malformation. European Archives of Oto-Rhino-Laryngology, 281:3943-3948, Mar 2024. URL: https://doi.org/10.1007/s00405-024-08555-7, doi:10.1007/s00405-024-08555-7. This article has 5 citations and is from a peer-reviewed journal.

  15. (jiang2023advancesingene pages 13-14): Luoying Jiang, Daqi Wang, Yingzi He, and Yilai Shu. Advances in gene therapy hold promise for treating hereditary hearing loss. Molecular Therapy, 31:934-950, Apr 2023. URL: https://doi.org/10.1016/j.ymthe.2023.02.001, doi:10.1016/j.ymthe.2023.02.001. This article has 127 citations and is from a highest quality peer-reviewed journal.

  16. (xu2024researchprogresson pages 1-2): Kaifan Xu, Yun Xiao, Jianfen Luo, Xiuhua Chao, Ruijie Wang, Zhaoming Fan, Haibo Wang, and Lei Xu. Research progress on incomplete partition type 3 inner ear malformation. European Archives of Oto-Rhino-Laryngology, 281:3943-3948, Mar 2024. URL: https://doi.org/10.1007/s00405-024-08555-7, doi:10.1007/s00405-024-08555-7. This article has 5 citations and is from a peer-reviewed journal.

  17. (bernardinelli2023clinicalandmolecular media 46a2f715): Emanuele Bernardinelli, Florian Huber, Sebastian Roesch, and Silvia Dossena. Clinical and molecular aspects associated with defects in the transcription factor pou3f4: a review. Biomedicines, 11:1695, Jun 2023. URL: https://doi.org/10.3390/biomedicines11061695, doi:10.3390/biomedicines11061695. This article has 13 citations.